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ABSTRACT 
Epilepsy, a common neurologic disorder in dogs, has also been recognized in the 
Finnish Spitz dog (FSD) since the 1980s, but scientifically verified data has been 
lacking. In this thesis, epilepsy in FSDs was characterized. Diagnostic investigations, 
using tools such as magnetic resonance imaging (MRI) and electroencephalography 
(EEG), have not been used consistently in veterinary medicine to diagnose epilepsy in 
dogs. The usefulness of these modalities to diagnose different forms of canine epilepsy 
needs to be proven. Thus, FSDs with and without focal epilepsy were studied by MRI 
and EEG. In addition, the novel functional method to investigate epileptic dogs, 2-
deoxy-2-[18F]fluoro-D-glucose (FDG) positron emission tomography (PET),  was 
described and results were compared with EEG.  
Epidemiological information was based on 2141 FSDs, of which 143 were epileptic, 
and prevalence on 2069 living FSDs, of which 111 had epilepsy. The prevalence of 
suspected idiopathic epilepsy (IE) in FSDs was found to be 5.3%; males were more 
predisposed to epilepsy. The median age at seizure onset was 3 years, seizure frequency 
was 3 per year, and duration of seizure episode was 12 min. Focal onset seizures, 
characterized by frequent behavioral and autonomic signs were the main phenotype of 
epilepsy in FSDs. Although epilepsy in FSDs follows a generally benign course, 
generalization of seizure indicate a progressive course of epilepsy. The heritability 
estimate of IE in FSDs (0.22) was best explained by polygenic traits.  
Although characterized with focal seizures, FSDs have non-lesional epilepsy based on 
1.5T MRI examinations. Infrequent reversible brain changes can be found, as a 
consequence of seizures. 
Visual evaluation of EEG in epileptic FSDs showed interictal epileptiform paroxysmal 
activity (20%) less frequently than had been described previously. This activity was 
expressed by spikes, polyspikes, and spike slow-wave complexes in the posterior-
occipital derivation. Epileptiform activity, consisting of midline spikes, was recognized 
in healthy FSDs. Sleep transients, which were frequently found in FSDs from both 
groups, could be easily misinterpreted as epileptiform activity. Quantitative EEG 
showed significant difference in various frequency bands related to diseased status or 
medication. 
Cerebral glucose utilization was examined by FDG-PET in 11 epileptic and 8 healthy 
FSDs. Glucose uptake abnormalities/asymmetries were detected in various brain 
regions of 82% of epileptic and in 50% of control FSDs; findings in the occipital cortex 
specifically associated with epilepsy. The epileptic dogs had significantly lower 
standardized uptake values in numerous cortical regions, cerebellum, and hippocampus 
compared to the control dogs. The low cortical glucose uptake values found in the 
occipital lobe in both groups of FSDs is an unique finding and may indirectly reflect the 
lowered seizure threshold in that region characteristic for this dog breed. Inability to 
reveal significant difference of white matter normalized uptake values and left-right 
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asymmetry indexes between epileptic and control groups might be related to the method 
used to define regions of interest.   
Based on these results, epilepsy in FSDs is defined as idiopathic epilepsy, as FSDs lack 
changes on the brain MRI and epilepsy is genetically determined. EEG and FDG-PET 
suggest involvement of the occipital region, although also wider posterior cortical areas 
could be related to epileptogenesis in FSDs. 
Visual evaluation of both EEG and FDG-PET can support the diagnosis of IE in dogs. 
Although diagnostic yield of EEG to diagnose epilepsy seems to be lower than 
suggested for dogs, it is a method of choice for everyday clinical settings. FDG-PET is a 
useful research modality for examining epileptic dogs, where visual detection of 
hypometabolic areas provides the highest sensitivity. Quantitative assessment methods 
of EEG and FDG-PET can be beneficial, but should be used alongside visual evaluation 
in epileptic dogs.  
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1. INTRODUCTION 
Idiopathic epilepsy (IE) is a common canine neurological problem with an estimated 
prevalence of 0.6% in the general dog population (Kearsley-Fleet et al. 2013). There is 
remarkable variability in published prevalence figures for different dog breeds (1 to 
33%) and study populations (Falco et al. 1974, Famula & Oberbauer 1998, Knowles 
1998, Berendt et al. 2002, Casal et al. 2006, Berendt et al. 2009, Gulløv et al. 2011). 
Breeding studies and pedigree analyses have supported a genetic basis for IE in a wide 
variety of dog breeds (Srenk et al. 1994, Famula et al. 1997, Jaggy et al. 1998, 
Kathmann et al. 1999, Patterson et al. 2005, Licht et al. 2007). It is most likely, 
however, that a number of genetic mutations can determine the IE in different dog 
breeds, but possibly also for distinct bloodlines within the same breed (Licht et al. 
2002). Increasing numbers of genetic studies of canine epilepsy have reported first loci 
and candidate genes for IE in dogs (Ekenstedt et al. 2011, Seppälä et al. 2011, 2012). 
Therefore a break-through in our understanding of the pathophysiological mechanisms 
underlying canine epilepsies may occur in the near future. 
Diagnosis of IE in dogs is generally made per exclusionem and based on a history of 
more than two seizures in the absence of other medical problems, normal physical and 
neurological examination, as well as clinical evaluations (Schwarz-Porsche 1984, Jaggy 
& Bernardini 1998, Licht et al. 2002). The Neuroimaging Commission of the 
International League Against Epilepsy (ILAE) suggested that magnetic resonance 
imaging (MRI) examination should be performed on every human patient with epilepsy 
(Kuzniecky et al. 2002). The situation in veterinary epileptology differs however, as a 
limited number of studies documenting MRI findings in dogs with seizures have been 
available (Kärkkäinen et al. 1991, Kärkkäinen 1995, Mellema et al. 1999, Mariani et al. 
2001, Bush et al. 2002). Nonetheless, there is a growing collection of publications 
exploring that field. In canine IE, similar to humans, structural brain imaging is 
considered to be normal. (Chandler 2006, Thomas 2010). 
Modern electroencephalography (EEG) has unfortunately not become a routine 
diagnostic procedure when diagnosing epilepsy in dogs (Pakozdy et al. 2012). It is 
surprising, as interictal EEG changes can be the only positive finding in dogs with IE. In 
addition to confirmation of epileptic cerebral activity, EEG can supply localization of 
the epileptogenic foci and play an important role in seizure classification (Commission 
on Classification and Terminology of the ILAE 1981, 1989, Flink et al. 2002). 
Diagnostic yield of EEG when examining dogs with epilepsy has been reported to be 
highly variable however (0% till 86%) (Jaggy & Bernardini 1998, Pakozdy et al. 2012). 
Thus, multiple methodological questions need to be answered regarding the use of EEG 
to diagnose epilepsy in dogs.  
Positron emission tomography (PET) using different radioligands have been used in 
epileptic human patients to confirm the epileptic region during presurgical evaluation. 
The most widely used tracer used with PET is 2-deoxy-2-[18F]fluoro-D-glucose (FDG) 
which reflects cerebral glucose utilization (Juhasz et al. 2005). Glucose metabolism in 
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focal epilepsy is usually reduced interictally in the region of seizure onset, and increased 
during the ictal event. The usefulness of FDG-PET when examining epileptic veterinary 
patients, however, remains unknown. 
The Finnish Spitz dog (FSD) is a relatively rare breed used traditionally in the Northern 
parts of Scandinavia as a “barking hunting dog” for game birds and also as a guard dog. 
Since the 1980s there was information available about the incidence of epilepsy in 
FSDs, but scientifically proved information was missing. This thesis characterizes 
epilepsy in FSDs and explores the usefulness of diagnostic modalities (MRI, EEG, and 
FDG-PET) and methods of analysis to investigate epileptic dogs.  
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2. REVIEW OF THE LITERATURE 
2.1. Epilepsy definitions and classifications 
Epileptic seizure is defined in human medicine as a transient occurrence of signs and/or 
symptoms due to abnormal excessive or synchronous neuronal activity in the brain 
(Fisher et al. 2005). From the pathophysiological point of view, it is important to 
appreciate that normal brain can also have an acute seizure as a natural response to 
transient insult or loss of homeostasis (provoked seizure) (Engel 2006). Epilepsy is 
defined for practical purposes as two or more unprovoked seizures occurring at least   
24 h apart (Thurman et al. 2011). The conceptual definition of epilepsy is rather 
complex and also includes the neurobiologic, cognitive, psychological, and social 
consequences of this condition, and is characterized by enduring predisposition of the 
brain to generate epileptic seizures (requires occurrence of at least 1 seizure) (Fisher et 
al. 2005). Some parts of the previous definition might be difficult to apply directly to 
animals, however, the definitions and terminology used in veterinary medicine follow 
the ILAE 1981–1989 recommendations for the most part (Commission of Classification 
and Terminology of the ILAE 1981, 1989), and are more recently modified after the 
2001–2006 update (Engel 2001, 2006). Epilepsies are classified according to etiology as 
idiopathic (primary), symptomatic (secondary), and probably symptomatic 
(cryptogenic) epilepsy (Berendt & Gram 1999). Some authors exclude cryptogenic from 
the classification and include reactive epilepsy (Bush et al. 2002, Lorenz et al. 2011a). 
Idiopathic epilepsy is defined as recurrent, unprovoked seizures for which no 
underlying brain abnormalities can be identified and a familial or genetic predisposition 
may be suspected (Knowles 1998). Symptomatic epilepsy refers to a seizure disorder 
where seizures are a consequence of a structural brain disorder (March 1998). Probably 
symptomatic epilepsy is suspected to be symptomatic, but where etiology is not 
determined (Berendt & Gram, 1999). Extracranial metabolic or toxic insults are causing 
reactive epilepsy and therefore not considered as true epilepsy (Chandler 2006). 
One recent study from the veterinary field has applied the term “genetic epilepsy” 
(Gulløv et al. 2012), adapted from the latest ILAE proposals (Berg et al. 2010). A 
modified concept of genetic, structural/metabolic, and unknown cause has been 
suggested to replace idiopathic, symptomatic, and cryptogenic. Accordingly, genetic 
epilepsy was defined as a direct result of a known or presumed genetic defect(s) in 
which seizures are core symptom of the disorder; structural/metabolic as a distinct other 
structural or metabolic condition or disease that has been demonstrated to be associated 
with a substantially increased risk of developing epilepsy and unknown cause with 
neutral meaning that the nature of the underlying cause is as yet unknown. (Berg et al. 
2010) 
Seizure type classification is based on the clinical signs of seizure onset. 
Symptomatology of a focal (partial) seizure is consistent with initial activation of only a 
part of one cerebral hemisphere (Blume et al. 2001) whereas involvement of both 
cerebral hemispheres from the beginning of seizure onset indicates generalized seizure 
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(Blume et al. 2001). Although a descriptive approach of consciousness and seizures is 
recommended by the newest ILAE guidelines for humans (Berg et al. 2010), dividing 
focal seizures based on the consciousness level as simple focal seizures (SFS) and 
complex focal seizures (CFS) (CFS impaired and SFS preserved consciousness) is still 
common in veterinary literature. Seizure propagation can occur when SFS progresses to 
a CFS or focal onset seizure to generalize (Berendt & Gram 1999). 
Epileptic seizures can be self limiting or continuous. When the duration of a seizure 
episode is longer than 30 min or a cluster of epileptic seizures lasts the same time 
without regaining a normal baseline of function between, it is defined as status 
epilepticus (Bateman et al. 1999, Walker 2005). Also a 5 min (Saito et al. 2001, Brophy 
et al. 2012) and a 10 min (Monteiro et al. 2012) duration have been used to define SE in 
the latest literature. The occurrence of more than one seizure episode during 24 h is 
named a cluster seizure (Monteiro et al. 2012). 
A seizure episode itself is named ictus and the period between the seizure episodes as an 
interictal period. An event shortly prior to the ictus characterized by sensory signs is 
referred as an aura (Berendt & Gram 1999). Behavioral signs without impairment of 
consciousness and without motor signs which precede hours or days (more than 1h) 
before the seizure are defined as prodrome. A period of behavioral changes, blindness 
etc., following the seizure episode (lasting minutes to hours) is called the post-ictal 
period. Prodrome and post-ictal signs are not counted as part of ictus, but aura (Berendt 
& Gram 1999) or short lasting behavioral, autonomic signs preceding ictus (< 1 h) 
(Licht et al. 2002) are considered to be part of the focal seizure onset. 
2.2. Epidemiology of epilepsy 
A broader spectrum of clinical epidemiological studies of epilepsy deals with classical 
concepts of incidence, prevalence, basic risk factors, and etiology in addition to a wider 
scope of socioeconomic questions, co-morbidities, and factors affecting outcome 
(Thurman et al. 2011). 
Epilepsy is the most common chronic neurological disorder in humans; approximately 
65 million people suffer from the disease worldwide. The annual incidence of epilepsy 
is 50 per 100,000 population in industrial countries (100-190/100,000/year in resource-
poor countries) and the prevalence of active epilepsy generally 5-10 per 1000 (Sander 
2003, Thurman et al. 2011). Lifetime prevalence rates in humans are much higher, as up 
to 5% of the population may experience seizures at some point in life (Sander 2003). 
Naturally occurring epilepsy is reported in many animal species including rodents, dogs, 
cats, horses, cattle, goats, and non-human primates (Chandler 2006). Seizures are also 
the most frequent neurological problem in dogs, with an estimated prevalence from 0.5 
to 5.7% (Licht et al. 2002), comprising 2-3% of canine patients treated at veterinary 
teaching hospitals (Podell et al. 1995) and involving 10% of neurological problems 
(Jaggy & Bernardini 1998). IE has been diagnosed in 25% (Berendt & Gram 1999) to 
80% of dogs with seizures (Schwarz-Porshe 1994). A number of dog breeds have been 
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described to have an increased risk of IE with the highest reported prevalence of 33% in 
the Belgian Shepherd family (Berendt et al. 2009).  
The genetic mechanisms of IE are likely to vary not only between breeds, but possibly 
even within the same breed (Licht et al. 2002). Recently described first loci and 
candidate genes for IE in dogs (Ekenstedt et al. 2011, Seppälä et al. 2012) represent the 
first steps to defining the epilepsy genes. LGI2 truncation has been demonstrated to 
cause benign focal onset juvenile epilepsy in Lagotto Romagnolos (Seppälä et al. 2011). 
In clinical medicine, approximately 70% of all epilepsy patients lack an obvious 
extraneous cause and are presumed to have a predominantly genetic basis and 40% are 
thought to have a complex genetic basis with an unknown number of susceptibility 
genes (Heron et al. 2007, Dibbens et al. 2007). Some dominant and autosomal recessive 
epilepsy genes are already known (Heron et al. 2007). Until now, the suggested modes 
of inheritance for IE in dogs include: autosomal recessive in Keeshonds (Hall & 
Wallace 1996), Vizsla (Patterson et al. 2003), Standard Poodles (Licht et al. 2007), 
Belgian Shepherds (Berendt et al. 2009), and Border Collies (Hülsmeyer et al. 2010); 
partially penetrant autosomal recessive in Irish Wolfhounds (Casal et al. 2006); and 
polygenic recessive in Golden Retrievers (Srenk & Jaggy 1996), Labrador Retrievers 
(Jaggy et al. 1998), and Bernese Mountain dogs (Kathmann et al. 1999). In Beagles, 
autosomal recessive and sex-linked suppressors have been reported (Bielfelt et al. 
1971). The male predisposition for IE has been reported for Golden retrievers (Srenk et 
al. 1994), Bernese Mountain dogs (Kathmann et al. 1999), and Irish Wolfhounds (Casal 
et al. 2006), when female prevalence was found in Belgian Shepherds (Berendt et al. 
2008). Overall 1.5 times higher predisposition to epilepsy in male dogs has been found 
in one study from the UK which included 539 dogs involving multiple dog breeds 
encompassing patients collected from veterinary practices (Kearsley-Fleet et al. 2013). 
Epidemiological studies of human epilepsy indicate a slightly higher incidence of 
epilepsy in males overall (Kotsopoulos et al. 2002), but gender susceptibility varying 
for specific epilepsy subtypes (Christensen et al. 2005). 
Many predisposing factors for epileptic seizures have been investigated in dogs, 
including feeding habits, time of day or year, the weather, lunar cycle, and sex cycle, 
but no significant associations have been made (Berendt et al. 2002, Hülsmeyer et al. 
2010, Browand-Stainback et al. 2011). Some authors have found that seizures usually 
occur at the time of rest or sleep (Langweiler & Jaggy 1998, Morita et al. 2002, Weissl 
et al. 2012). On the other hand, various nonspecific stress situations have also been 
reported to trigger seizures in a high proportion of dogs (Heynold et al. 1997, Berendt et 
al. 2008, Hülsmeyer et al. 2010). High stress levels and significant life events acting as 
precipitating factors for seizure occurrence have also been documented in both humans 
(Temkin & Davis 1984, Koutsogiannopoulos et al. 2009) and some animal epilepsy 
models (Joels 2009).  
Numerous predictors of seizure outcome have been suggested in human epilepsy, such 
as sex, seizures in relatives, prior neonatal seizures, prior febrile convulsions, age at 
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seizure onset, abnormal neurological status, seizure frequency at onset of seizures, 
seizure etiology, type and number of seizure types, type of epilepsy syndrome, time 
prior to the onset of drug therapy, number of seizures prior to the onset of drug therapy, 
age at the onset of drug therapy, the early effect of drug therapy, and the number 
seizures during early drug therapy (Sillanpää 2000). In contrast, only a few factors have 
been found to be predictors of epilepsy outcome in dogs, such as early initiation of 
treatment, an advanced age at seizure onset, and a high body weight (Heynold et al. 
1997, Saito et al. 2001, Berendt et al. 2007, Hülsmeyer et al. 2010). A significantly 
shorter life span has been reported for dogs in which euthanasia or death was directly 
caused by epilepsy, and epileptic females live longer than males (Berendt et al. 2007). 
Some breeds have a shorter life span with IE, including Australian Shepherd dogs 
(Weissl et al. 2012), Border Collies (Monteiro et al. 2012, Hülsmeyer et al. 2010), and 
Irish Wolfhounds (Casal et al. 2006). Other breeds, like German Shepherds and Boxers, 
have been found to have a high occurrence of cluster episodes as a criterion for poor 
prognosis (Monteiro et al. 2012). On the contrary, no significantly shortened life span 
has been found in the family of Belgian Shepherds with genetic epilepsy, despite a 
majority of deaths related to epilepsy (Gulløv et al. 2012). Expected life span in dogs 
with IE has also been reported in another study, but status epilepticus was found as a 
factor shortening survival time (Saito et al. 2001). In dogs with juvenile IE, survival 
time was shortened with a history of status epilepticus. Diagnosis of symptomatic 
epilepsy and number of antiepileptic drugs used before investigation also shortened 
survival in dogs with juvenile epilepsy (Arrol et al. 2012). One study found a negative 
influence of neutering on the occurrence of cluster episodes (Monteiro et al. 2012), 
whilst others found that neutering may influence seizure frequency and seizure severity 
in female Belgian Shepherds (Berendt et al. 2008). Genetic studies have demonstrated 
polymorphism in the ABCB1 gene to be associated with Phenobarbital treatment and 
seizure outcome in border collies (Alves et al. 2011) and collies (Muñana et al. 2012), 
but not in Australian Shepherd dogs (Weissl et al. 2012). 
Epilepsy remission rates have been reported to vary from 13.7% in Belgian Shepherds 
(Gulløv et al. 2012) to 24% in Danish Labrador retrievers (Berendt et al. 2002), but 
nearly all Lagotto Romagnolos with benign juvenile epilepsy have had remission 
(Jokinen et al. 2007). However, as the remission has not been determined in a constant 
way (seizure freedom minimally 1 to 3 years), direct comparison between the studies 
and breeds may be complicated (Berendt et al. 2002, Berendt et al. 2007, Hülsmeyer et 
al. 2010). In humans over 70% of epileptic patients will be suspected to enter remission 
(Sander 2003). 
2.3. Clinical phenotype of epileptic seizures   
An epileptic seizure is a clinical event and can affect motor, sensory, and autonomic 
function, consciousness, emotional state, memory, cognition, or behavior, depending on 
location of onset in the brain (Fisher et al. 2005). Some signs from this wide range of 
epileptic phenomena recognized in humans are complicated or nearly impossible to 
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assess in animals. Therefore a simplified approach to classify seizures in animals should 
be more appropriate.  
Canine ictus may be evident from motor, behavioral or autonomic signs as a single 
nominator or in different combinations. Motor signs are isolated to a body part or are 
unilateral when focal and presented as tremors, tonic or clonic movements, difficulties 
to walk or stand, or abnormal body deviations. They have been recognized from 45% 
(Hülsmeyer et al. 2010) to 100% (Licht et al. 2002) of dogs. Psychic or behavioral signs 
have been occurring from 10% (Licht et al. 2002) to 92% (Gulløv et al. 2011) of dogs 
and are defined as paroxysmal signs of anxiety, restlessness, unprovoked aggression, 
and/or out of context behavior. Compulsive tail chasing, fears, hyperactivity, and 
phobias in Bull terriers might be related to focal seizure activity (Dodman et al. 1996). 
Epigastric sensations, papillary dilatation, lacrimal secretion, and urinary or fecal 
incontinence are described autonomic signs and occur in between 23% (Berendt et al. 
2004) and 67% (Licht et al. 2002) of dogs. Automatism has been defined in clinical 
medicine as more or less coordinated, repetitive, motor activity usually occurring with 
impaired cognition (Blume et al. 2001). Seizure related behaviors such as chewing or 
swallowing movements, lip smacking, body scratching, as well as changing position or 
circling when performed repeatedly have been interpreted in veterinary literature as 
automatisms and therefore indicative to impaired consciousness (Licht et al. 2002). For 
assessment of consciousness in dogs, responsiveness when owner tries to get their 
attention and ability to keep attention, in addition to whether the animal is able to 
navigate in any way (to walk, run or jump) have been applied (Licht et al. 2002).  
Focal seizures, with or without secondary generalization, have been reported to be the 
predominant seizure type of IE for multiple dog breeds, including Dalmatians and 
Standard Poodles (Licht et al. 2002), Labradors retrievers (Berendt et al. 2002), Vizslas 
(Patterson et al. 2003), Belgian Shepherds (Berendt et al. 2008), Border Collies 
(Hülsmeyer et al. 2010), and Petit Basset Griffon Vendeen (Gulløv et al. 2011). Focal 
seizures with generalization, however, are the most frequent seizure type. A high 
incidence of generalized seizures (75-90%) has been previously reported in dogs with 
IE (Schwarz-Porshe 1994, Jaggy & Bernardini 1998). Since more recent veterinary 
studies have started to pay attention to the initial clinical signs preceding the generalized 
phase of seizure, seizures have been classified as generalized less frequently in dogs 
(Licht et al. 2002). Generalized seizures have been reported to be the predominant 
seizure type in Irish Wolfhounds (Casal et al. 2006), and also involving almost half of 
the seizures in English Springer spaniels with IE (Patterson et al. 2005).  
During generalized seizure, animals may fall to the side and lose consciousness at some 
point. Motor signs are bilateral and largely symmetrical, most frequently tonic-clonic 
movements are observed during generalized seizure phase, but tonic, clonic, myoclonic, 
or atonic signs are also described in dogs. Canine absence seizures are complicated to 
define, although described when accompanied with myoclonic features (Poma et al. 
2010). Automatisms as coordinated paddling of four limbs can be seen. In generalized 
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seizures, autonomic signs can be observed nearly as frequently as motor signs (Licht et 
al. 2002). The post-ictal phase in dogs is characterized by restlessness, thirst, hunger, 
aggression, or brief post-ictal blindness (Hülsmeyer et al. 2010). The duration of the 
post-ictal phase has been shown to increase with disease progression (Weissl et al. 
2012).  
A number of characteristics have been shown to be significantly different when 
comparing seizures in dogs with IE and symptomatic epilepsy, including: age, body 
weight, presence of partial seizures, cluster seizures, status epilepticus, ictal vocalization 
and neurological deficits (Pakozdy et al. 2008). IE has been reported to be more 
probable in dogs that are between 1 and 5 years at the time of seizure onset, if the 
seizure occurred between 8 am and midnight, or in dogs over 15 kg or if the interval 
between the first and the second seizure exceeded 4 weeks (Podell et al. 1995). Median 
seizure onset has been reported to be between 2 and 3 years for numerous dog breeds, 
but the seizure onset ranged from 2 months to 10 years (Jaggy & Bernardini 1998, 
Kathmann et al. 1999, Patterson et al. 2003, Patterson et al. 2005, Casal et al. 2006, 
Hülsmeyer et al. 2010). Dogs with juvenile forms of IE might start to have seizures as 
early as 5 weeks of age (Jokinen et al. 2007, Arrol et al. 2012).  
2.4. Diagnosis of idiopathic epilepsy  
Diagnosis of epilepsy is primarily based on the history of recurrent seizures, but general 
physical and detailed neurological examinations are basic assessments that should be 
performed on every animal with the history of seizures in order to detect changes 
indicative of symptomatic epilepsy or of general disease conditions (Lorenz et al. 
2011a). Dogs diagnosed with IE are supposed to have no neurological deficits when 
examined interictally. Some neurological deficits (i.e. disorientation, blindness) may 
persist when the animal is examined during the post-ictal period even longer than 24 h 
(Hülsmeyer et al. 2012).  
2.4.1. Laboratory diagnostics 
Laboratory diagnostics, including complete blood count, serum chemistry profile, and 
urine analysis, are often considered to be the minimal required examinations for the 
diagnosis of IE in order to exclude extracranial causes for seizures (Thomas 2010). A 
serum chemistry profile includes glucose, total protein, albumin, globulin, blood urea 
nitrogen, creatinine, total bilirubin, alanine aminotransferase, aspartate 
aminotransferase, alkaline phosphatase, creatine kinase, cholesterol, and electrolytes 
(Na, K, Ca, P, Mg). Paired serum bile acids, collected after 12 h fasting and 
postprandial, have been used in young animals to rule out a portosystemic shunt 
(Webster 2005). Specific gravity, chemistry, and sediment examinations should be 
performed from urine samples. An increasing number of diseases that cause seizures in 
dogs can also be confirmed from various tissue samples using genetic tests (Lohi et al. 
2005, Awano et al. 2006). 
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Cerebrospinal fluid (CSF) is collected by a cerebellomedullary cisternal puncture under 
general anesthesia and used to rule out intracranial inflammatory, infectious, or 
neoplastic diseases. Total cell counts can be measured using a hemocytometer or mirror 
counting chamber. Differential white blood cell counts and cytological examinations 
can be performed on samples prepared with a cytocentrifuge or after sedimentation 
methods to concentrate cells (Lorenz et al. 2011b). For measurements of protein 
concentration in the CSF, qualitative methods such as the Pandy test, or quantitative 
analysis can be performed. Increased protein level in CSF is a non-specific indicator of 
central nervous system pathology. In the dogs with IE, CSF should remain within 
reference range regarding total nucleated cell count (< 5 cells/ul) and protein level (< 
250 mg/l). A mild increase in total cell count of the CSF early after ictus may occur 
(Goncalves et al. 2010). Electrophoresis is used to quantify the levels of protein 
fractions or immunoglobulins (Lorentz et al. 2011b) and measurements of C-reactive 
proteins in CSF in order to exclude inflammatory processes within central nervous 
tissue (Martinez-Subiela et al. 2011). Levels of neurotransmitters, such as γ-
aminobutyric acid, glutamate, and aspartate, may be lower in dogs with IE, but not 
equally in all dog breeds (Ellenberger et al. 2004). The ability to identify a definitive 
diagnosis from the CSF can be improved with microbiologic testing, measurement of 
antibody titers, polymerase chain reaction (PCR) testing, and immunocytochemistry 
(Lorenz et al. 2011b). CSF analysis has been demonstrated to be of value as it is an 
indicator of central nervous system pathology; MRI shows changes in only 6% of dogs 
with seizures and with normal interictal neurological examination and CSF results while 
MRI abnormalities were present in 43% of dogs with abnormal CSF and normal 
neurologic examination results and in 97% of dogs with abnormalities detected in both, 
in CSF and neurologic examination (Bush et al. 2002). 
2.4.2. Magnetic resonance imaging (MRI) 
The physical nuclear magnetic resonance phenomenon was discovered 1946, but the 
first applications of medical imaging appeared much later – in the 1980s (Jackson et al. 
2005a). MRI is based on the visualization of the hydrogen atoms nucleus using strong 
magnetic field and radiofrequency pulses (Jackson et al. 2005b, Gavin 2009). For the 
routine imaging of the neurocranium, T1-weighted (T1W) and T2-weighted (T2W) 
images in 3 standard planes (i.e. sagittal, transverse, dorsal) are used. Multiplanar 
reconstruction (MPR) which is 3D of T1W sequence could be used instead of T1W 
images and reconstructed later in all standard planes. Inversion recovery sequences as 
fluid-attenuated inversion recovery (FLAIR) can be used to improve delineation of 
primary lesions from the oedematous changes and distinction between the gray and 
white matter (Blümcke 2011, Bagley et al. 2009). Diffusion-weighted imaging could be 
applied when brain infarction is suspected (Major et al. 2012). Repeating T1W images 
or MPR after injection of paramagnetic contrast agent (i.e. gadolinium - dimeglumine 
gadopentate) is indicated when inflammatory or neoplastic changes, altering the blood-
brain-barrier of the cerebral vasculature are suspected (Bagley et al. 2009). Contrast 
agents generally cause an increase in T1W signal which is recognized as increased 
hyperintensity in T1W images (Gavin 2009).  
 Review of the literature  
20 
 
MRI is considered the most valuable diagnostic tool for investigating the etiology of 
epilepsy in vivo because the detection of lesions is an important factor in planning 
epilepsy management and in predicting the prognosis of individual human patients. 
Over 80% of humans with epilepsy have a focal epilepsy, and only 43% have a cerebral 
lesion (Lee et al. 2002). MRI identifies lesions more frequently in patients with 
temporal lobe epilepsy (76%) than with extratemporal epilepsy (47%) (Casse et al. 
2002). Hippocampal sclerosis, the main cause of temporal lobe epilepsy in humans, is 
detected by MRI in approximately 55% of the patients (Lehericy et al. 1997). The 
detection of lesions has improved since the application of higher strength magnetic 
fields and computer-based postprocessing analysis (Kuzniecky et al. 2002, Knake et al. 
2005). In addition to visual evaluation of the images, different quantitative 
measurements can be applied. Hippocampal MRI volumetry is an established technique 
and performed in epileptic humans with high confidence (Jackson & van Paesschen 
2002, Jeukens et al. 2009). 
The majority of veterinary MRI studies are performed using low magnetic field 
equipment (Konar & Lang 2011); although, some recent publications indicate that 
animals also might benefit from the use of 3 or 7 T MRI machines (Kang et al. 2009, 
Martin-Vaquero et al. 2011). MRI examinations are used increasingly for epileptic 
canine patients, but are more frequently performed to examine patients with suspected 
symptomatic epilepsy. MRI findings from the dogs having seizures as a result of brain 
tumors (Thomas et al. 1996, Kraft et al. 1997, Bush et al. 2002, Cherubini et al. 2005, 
Schwartz et al. 2011), inflammation (Sawashima et al. 1996, Kuwabara et al. 1998, 
Mariani et al. 2001), vascular problems (Kitagawa et al. 2008, Timm et al. 2008), 
malformations (Kitagawa et al. 2003, Jeffery et al. 2003, Jeffery 2005, Davies et al. 
2013), and metabolic diseases (Garosi et al. 2003, Moon et al. 2012) have been 
described. In dogs, MRI has been approved to be both sensitive and specific for 
identifying brain lesions and classifying disease as inflammatory or neoplastic, with the 
exception of cerebrovascular disease in general or specific inflammatory or neoplastic 
disease, which can frequently be misclassified (Wolf et al. 2012). A low-field MRI 
study on canine seizures, associated with normal interictal neurological examination and 
no identifiable metabolic cause, has reported brain changes in 2.2% of dogs younger 
than 6 years and 26.7% of dogs older than 6 years (Smith et al. 2006). Structural 
imaging with MRI is suspected to be within normal limits in dogs with IE (Chandler 
2006, Thomas 2010). MRI results might also be invariably normal (Bagley et al. 2009) 
or reveal only mild nonspecific changes (Koie et al. 2004) in dogs with degenerative 
and metabolic diseases.  
Seizure activity may cause structural brain changes that are most likely to occur when 
MRI is performed within 24 h from the seizure episode. These changes are seen as focal 
hyperintensive regions on T2W sequences and may be reversible when adequate seizure 
control is reached. Changes are suspected to resolve between 10 to 16 weeks following 
seizures.(Mellema et al. 1999) Hippocampal sclerosis is known to be a secondary 
pathology in humans and dogs, because hippocampal neurons are vulnerable to 
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excitotoxic damage by intense and prolonged seizure activity (Jackson & van Paesschen 
2002, Buckmaster et al. 2002, Fatzer et al. 2000). Secondary hippocampal changes in 
the brains of dogs with suspected IE have been reported (Hasegawa et al. 2002, Morita 
et al. 2002). Pseudolesions in the hippocampus region have been described in MRI of 
seizuring dogs which appear to be artifacts caused by the fat containing petrous 
temporal bone (Cooper et al. 2010). 
An automatic voxel-based morphometry technique is described for the canine model of 
aging to assess regional gray and white matter brain atrophy and provide higher 
diagnostic yield compared to the manual ROI drawing method (Tapp et al. 2006). 
Lateralized hippocampal atrophy in epileptic dogs was demonstrated using MRI in one 
exceptional study. When hippocampal atrophy was observed in 12% of epileptic dogs 
using visual evaluation of images, volumetry then described an asymmetry ratio of more 
than 6% observed in 48% of epileptic dogs. (Kuwabara et al. 2010) Another recent 
study pointed out difficulties in using hippocampal volumetry in dogs, namely large 
variation in canine skull size, poor interobserver agreement, and amount of time 
required to perform volumetry (Milne et al. 2013).  
2.4.3. Electroencephalography (EEG) 
The EEG is a record of the spontaneous electrical activity of the cerebral cortex. This 
method has been used in human patients to diagnose and manage epilepsy since 1935 
when Gibbs and colleges described spike and wave discharges (Pillai & Sperling 2006). 
The EEG became commonly used in the 1950s, but the importance of clinical EEG has 
been diminished during the past 30 years, except for epilepsy (Niedermeier & Schomer 
2011). In addition to confirmation of epileptic cerebral activity, EEG can supply 
detailed localization of epileptogenic foci and thereby play an important role in seizure 
classification (Commission of Classification and Terminology of the ILAE 1981, 1989, 
Flink et al. 2002). According to guidelines for EEG methodology in the diagnosis of 
epilepsy (Flink et al. 2002) the use of “modified combined nomenclature” derived from 
10-20 system for electrode location is advised (Klem et al. 1999). Routine montages 
should include bipolar montages with longitudinal and transverse chains and referential 
montages. The duration of recording time should include a minimum of 30 min of 
artifact free recordings. (Flink et al. 2002) 
EEG recordings are interpreted on the basis of the frequency and amplitude of 
background rhythms, the presence or absence and distribution of abnormal events and 
precise characteristics of abnormal events (Pillai & Sperling 2006).  
Background rhythms are distributed to the spectral frequency bands namely defined in 
humans as delta (0.5–4 Hz), theta (4–8 Hz), alpha (8–13 Hz), and beta (14–40.0 Hz) 
(Noachtar et al. 1999). The gamma frequency band also described in humans (>40Hz) is 
not considered in veterinary studies. Epileptiform activity can be found in interictal 
EEG of epileptic patients and consists of transients clearly distinguishable from 
background activity, with characteristic spike morphology (Noachtar et al. 1999). These 
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paroxysms of epileptiform activity represent the summation of excitatory and inhibitory 
postsynaptic potentials associated with hypersynchronous neuronal firing with 
paroxysmal depolarization shift and following hyperpolarization (Pillai & Sperling 
2006).  
In human patients with a history of seizures, focal interictal discharges suggest 
diagnosis of localization related epilepsy, and the character and location of changes may 
suggest etiology of the epilepsy syndrome and location of the epileptogenic region 
(Pillai & Sperling 2006). Generalized epileptic discharges are a hallmark of one of the 
generalized epilepsy syndromes, including idiopathic and symptomatic generalized 
epilepsies. (Stern 2005)  
Interictal epileptic discharges have been detected by EEG in 29% to 55% of human 
patients (Pillai & Sperling 2006). When outpatient EEG is repeated up to four times, 
detection of interictal epileptic discharges could rise up to 90%. EEG sensitivity is 
highest in children and lowest in elderly patients. (Stern 2005) Epilepsy medication with 
benzodiazepines and barbiturates decrease the occurrence of interictal epileptic 
discharges, but only when given acutely. Importantly, not all interictal spikes and sharp 
waves are associated with epilepsy (i.e. benign epileptiform transients of sleep, wicket 
spikes, rhythmic midtemporal  theta discharges, vertex sharp waves, and midline theta 
rhythm) and are considered as benign findings unrelated to seizure disorders. (Pillai & 
Sperling 2006) 
Sleep has been known to increase detection of interictal epileptiform discharges and 
ideally EEG recording should include 30 min of sleep. Sleep recording has been 
reported to detect epileptic discharges in 40% of humans on whom no epileptic 
discharges where seen at wakefulness. Sleep deprivation for 24 h increases the detection 
of epileptic discharges by 20% or more. (Pillai & Sperling 2006) 
The effect of hyperventilation is most impressive with absence seizures when it 
increases generalized spike–wave activity in 50-80% of patients. The hyperventilation 
may activate focal epileptic discharges in 6% of patients with complex focal seizures 
and clinical seizures in over 4% of patients. (Pillai & Sperling 2006) 
Photic stimulation induces epileptic discharges in many epileptic patients. It usually 
signifies a variety of generalized epilepsy syndromes. According to some authors, 
photic stimulation may trigger epileptiform discharges in patients with focal seizures 
when they arise from the occipital lobe. (Pillai & Sperling 2006) 
Interictal epileptic discharges may rarely occur in children (1.9–3.5%) and adults (0.2–
0.55) without epilepsy. Interictal epileptic discharges in some locations are less likely to 
indicate epilepsy, as only 40% of patients with central-mid-temporal spikes, or 50% 
with occipital spikes, have seizures (Stern 2005, Pillai & Sperling 2006). Therefore 
EEG findings should always be interpreted in the context of clinical history, physical 
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examination, and neuroimaging findings, otherwise misdiagnosis is possible. (Pillai & 
Sperling 2006) 
Long-term video-EEG may be the only method to distinguish epileptic from non-
epileptic seizures and is performed on hospitalized patients. When suspecting ictal 
signs, patient responsiveness and muscle tone, etc. could be tested. (Flink et al. 2002) 
Video-EEG recording could also potentially be employed in the future for animal 
patients. However, multiple methodological issues need to be resolved before good 
quality long-term recordings on awake animals could be applied to everyday epileptic 
canine patients. 
In the backwash of human EEG research, veterinary investigators started to publish 
about the EEG in dogs and cats. Methods of interpreting animal recordings were 
adapted from human EEG. Despite extensive work done in the 1960s until the mid-80s 
(Croft 1962, Redding 1964, Klemm 1968a, 1968b, Redman et al. 1973, Knecht et al. 
1984), EEG never reached a similar importance in diagnosing epilepsy in dogs, relative 
to human patients. Early studies were made on conscious animals (Croft 1964). Later 
numerous restraints were employed when examining dogs with the EEG, associated 
with a variety of needle placements and montage protocols, but no consensual 
agreements about standard EEG protocols have been reached (Itamoto et al. 2002, 
Bergamasco et al. 2003, Pellegrino & Sica 2004, Davis et al. 2011, James et al. 2011).  
In sedated dogs, there is a predominance of high frequency and high amplitude 
background rhythms (δ and θ) of the EEG (Moore et al. 1991, Itamoto et al. 2002, 
Bergamasco et al. 2003) whilst in conscious animals, low amplitude (<20uV) and high 
frequency rhythms are more prevalent (Klemm 1989). In visual evaluation of the EEG 
from sedated dogs, normal sleep transients as spindles, k-complexes, vertex sharp 
transients, and positive occipital sharp transients can be found (Bergamasco et al. 2003). 
Epileptiform paroxysmal discharges can be seen as a focal or generalized pattern 
consisting of spikes, polyspikes, sharp waves, and spike-and-slow-wave complexes that 
can be interictally recorded from epileptic dogs (Holliday & Williams 1998, Berendt et 
al. 1999, Brauer et al. 2011), but these findings do not indicate certain etiology. Some 
authors have claimed that generalized epileptiform discharges are more indicative of IE 
and symptomatic epilepsy should be suspected when focal epileptic activity is found on 
the EEG (Holliday & Williams 1998). Some low frequency focal changes without 
spikes might be indicative of symptomatic epilepsy (Klemm 1989, Berendt et al. 1999). 
EEG abnormalities are paroxysmal in dogs with IE whereas in dogs with symptomatic 
seizures, abnormalities appear nearly all the time (changes in focal background) and 
might be somewhat helpful (Klemm 1989, Holliday & Williams 1998).  
The incidence of interictal paroxysmal discharges on the EEG in dogs with epilepsy has 
been reported to range from 55% to 99% (Klemm & Hall 1970, Jaggy & Bernardini 
1998, Berendt et al. 1999, Pellegrino & Sica 2004). However, recent publications have 
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suggested a much lower diagnostic yield of EEG (0-25%) when examining dogs with IE 
interictally (Brauer et al. 2012, Pakozdy et al. 2012). 
In canine EEG, the effects of selected activation techniques like photic stimulation and 
hyperventilation have been shown to be of little value (Holliday et al. 1970, Brauer et 
al. 2011, 2012). Continuous EEG has been used for monitoring the status epilepticus in 
dogs and cats (Raith et al. 2010). There is some evidence that interictal EEG would 
show a decrease of paroxysmal discharge detection rate when following efficacy of 
antiepileptic medication in epileptic dogs (Wrzosek & Nicpon 2012). EEG has been 
used in evaluating the efficacy of gold wired implants inserted to acupuncture points in 
dogs with uncontrolled seizures (with IE); no changes were noted in quantitative EEG 
despite clinical seizure reduction by at least 50% (Goiz-Marquez et al. 2009). In 
addition, EEG has been used to distinguish paroxysmal dyskinesia in Chinook dogs 
from epileptic seizures (Packer et al. 2010). The radio-telemetric method to record EEG 
in awake dogs to evaluate proconvulsant risk of the medication in safety pharmacology 
has been also described (Dürmüller et al. 2007). 
2.4.4. Positron emission tomography (PET) 
PET was developed in the 1970s and has been increasingly used during last couple of 
decades as a research tool, but also for many clinical fields, e.g. in neurology, oncology, 
and cardiology (Casse et al. 2002, Juhasz al. 2005, Alavi et al. 2011). PET scanning 
allows noninvasive measurements of physiological and biochemical processes in vivo 
using compounds of interest labelled with short-living positron emitting isotopes such 
as 
15
O (half-life 2 min), 
11
C (20 min), and 
18
F (110 min) (Brooks 1991). These positron- 
emitting radionuclides are produced with accelerators, typically cyclotrons (Saha et al. 
1992). The PET scanners are based on detection of the annihilation photons in 
coincidence. The positron is the antiparticle of the electron and it has the same resting 
mass, but has a positive charge. Positrons are emitted when a proton in the proton-rich 
nucleus of an atom becomes a neutron. The positron combines with the electron after it 
has been traveling a few millimeters in the tissue. After the formation of the extremely 
short living positronium, the two particles annihilate, converting their mass to energy 
which is in the form of two 511-keV annihilation photons (gamma ray). (Fahey 2001) 
These photons move away from each other at the angle of 180 degrees, allowing 
external detection of them (Phelps & Mazziotta 1985). Circumferentially located 
radiation detectors of a PET scanner detect the number of emitted photons, but counting 
only coincidence photons (detected within 10 ns) (Fahey 2001). Spatial resolution of 
PET is limited by the factor that the scanner detects not the place of positron emission 
which is question of interest, but the point of annihilation (Phelps & Mazziotta 1985). 
Accuracy of the PET scanner largely depends on the size and cross sectional geometry 
of the detectors (Fahey 2001, Juhasz et al. 2005) Therefore spatial resolution of even 
modern very high resolution small animal PET scanners is close to a millimeter (Park et 
al. 2007), which is about the distance the positron travels (Fahey 2001).  
 Review of the literature  
25 
 
Data collected with PET is reconstructed to a cross-sectional image of the distribution 
of the PET tracer in the subject (Phelps & Mazziotta 1985). In static imaging, the tracer 
uptake is averaged during a determined time in steady-state, whereas in dynamic 
scanning, series of images are produced showing changes across time. 
PET examinations are usually available only from special institutions as they require 
expensive specialized equipment, generally including a cyclotron on site because of 
short isotope half-lives (Saha et al. 1992). Importantly, radioactivity exposure may limit 
the possibility of several PET investigations on the same subject or to control 
individuals. 
The most widely used PET tracer in epilepsy in humans with PET is FDG which 
reflects glucose utilization. FDG is transported to the tissue and phosphorylated like 
glucose by hexokinase. Unlike glucose, 2-deoxyglucose-2-fluoro-6-phosphate cannot be 
further phosporylated and gets trapped in the tissue in proportion to the local rate of 
glucose utilization. In the brain, this reflects synaptic density and functional activity of 
the brain tissue (Juhasz et al. 2005). A 3-compartment tissue model was developed by 
Sokolof to describe the uptake and metabolism of 2-deoxyglucose (Sokolof 1981). This 
model has been accepted for PET studies using the FDG, which is found to retain the 
same chemical properties with 2-deoxyglucose. Importantly, this model is applicable 
only for the steady-state condition. 
Cerebral metabolism and blood flow are markedly increased in the epileptic focus 
during the ictal period, but interictally cerebral metabolic activity declines below normal 
levels (Alavi et al. 2009). Suggested mechanisms for interictal cerebral glucose 
hypometabolism include neuronal loss, reduction of synaptic density in pathways 
involved in seizure onset and spread, and interictal inhibitory processes. In IE, the 
hypometabolism is most likely an indication of interictal inhibitory processes. (Casse et 
al. 2002) 
In clinical epileptology FDG-PET is mainly indicated for human patients with 
medically refractory seizures for presurgical evaluation when brain MRI is normal or 
shows only nonspecific abnormalities (Commission of Classification and Terminology 
of the ILAE 2000). Interictal FDG-PET has the highest diagnostic yield in patients with 
temporal lobe epilepsy (up to 90%) (Juhasz et al. 2005). Importantly, FDG-PET has 
shown correctly lateralized hypometabolism in 80% of patients with temporal lobe 
epilepsy and with normal MRI (la Fougere et al. 2009) and in more than 50% of patients 
with non-lateralizing surface ictal EEG (Juhasz et al. 2005). Therefore in many patients, 
FDG-PET could replace invasive intracranial EEG recordings in presurgical evaluation. 
However, it has been demonstrated, using ictal intracranial EEG recordings, that the 
hypometabolic regions seen in FDG-PET are not strictly confined to the seizure onset 
zone, but commonly extend beyond that and some hypometabolic cortical regions are 
not involved in seizure onset or early seizure propagation (Juhasz et al. 2005, Alkonyi et 
al. 2009). Hypometabolic cortical areas in interictal FDG-PET which are distant from 
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the suspected seizure onset zone may represent the functional deficit zone and be 
associated with psychiatric comorbidities (Goffin et al. 2008). One possibility to 
increase the accuracy of the visual findings of hypometabolic regions is to perform 
additional comparison with a template (based on normal patients) (Goffin et al. 2008, 
Kumar et al. 2010). Some novel PET tracers, like [
11
C]flumazenil-PET which allow the 
demonstration of reduced benzodiazepine receptor binding, have been shown to reflect 
actual brain damage more reliably than FDG in temporal lobe patients (Lamusuo et al. 
2000). The sensitivity of interictal FDG-PET for extratemporal epilepsies is almost half 
that reported for temporal lobe epilepsy (30-60%), depending on the localization of the 
epileptogenic focus (la Fougere et al. 2009).  
Visual evaluation of FDG images is the basic assessment method applied in human 
epileptology. It is based on detection of regional asymmetrical changes in FDG uptake 
(Varrone et al. 2009). To minimize bias, it is advised to make the initial visual 
interpretation without clinical information or structural imaging information. These 
results are later correlated with clinical information, also comparing images of the 
patient and healthy controls for interpretation. It is emphasized that scans should be 
obtained with the same camera. (Neuroimaging Subcommission of the ILAE 2000) 
Coregistering of FDG-PET data with MRI of the patient is considered optimal for 
analysis (Neuroimaging Subcommission of the ILAE 2000, Cho et al. 2008).  
Numerous quantification methods are used for functional neuroimaging, including 
FDG-PET. Regions of interests (ROI) on the different brain areas may be drawn on the 
single two-dimensional plane or on multiple planes which will be consolidated as 3-
dimensional volumes of interests (VOI). Standardized uptake value, SUV, is a widely 
used, simple PET quantifier, calculated as a ratio of tissue radioactivity concentration 
(kBq/g), and injected dose (MBq) at the time of injection divided by body weight (kg). 
SUV is the most often used semi-quantitative measure also in veterinary FDG-PET 
literature (Irimajiri et al. 2010, Lee et al. 2010a, 2010b, Kang et al. 2012). When 
interpreting SUV values, large variations related to scanners, image acquisition, 
reconstruction, and ROI methodology should be taken into account (Westerterp et al. 
2007, Varrone et al. 2009). To improve this comparison, the relative SUV ratio can be 
used, where the regional uptake is normalized with the uptake of the whole brain (Kang 
2012). Normalization of uptake values with white matter, cerebellar, or brainstem 
regional activity can be preferred in some situations (Koivunen et al. 2008, Berti et al. 
2012). 
To semi-quantitatively evaluate lateralization of changes the left-right asymmetry index 
(AI) for all pairs of homologous VOIs can be calculated. In the formula AI= (L-R) x 
100/([L+R]/2)%, positive AI indicates reduced glucose metabolism in the right and 
negative in the left side VOI. In epileptic human patients asymmetry between 10-15% 
indicates possible areas of reduced glucose utilization and over 15% indicates clear 
regions of hypometabolism. (Lamusuo et al. 2001) 
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Recently some studies have addressed the description of cerebral glucose metabolism 
measured by FDG-PET in healthy control dogs (Irimajiri et al. 2010, Lee et al. 2010a, 
2010b, Hansen et al. 2011). One study has described SUV values for detailed brain 
regions using coregistration of high-resolution PET and 7T MRI. (Kang et al. 2012) The 
mean brain SUVs for dogs was ranging from 3.4 to 7.4 with a relative SUV of 1.0. 
(Irimajiri et al. 2010, Lee et al. 2010, Hansen et al. 2011, Kang et al. 2012). Focal 
cerebral glucose hyper- or hypometabolism caused by different types of encephalitis 
using the FDG-PET are also reported in dogs with seizures (Eom et al. 2008, Kang et al. 
2010). 
Regional brain perfusion, examined with interictal single-photon emission computed 
tomography (SPECT), another functional imaging modality, has also been reported in 
epileptic dogs recently (Martle et al. 2009). 
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AIMS OF THE STUDY 
The aims for this study were as follows: 
1. To characterize phenotype, epidemiological characteristics, and inheritance of 
epilepsy in Finnish Spitz dogs. 
2. To define typical findings of advanced diagnostic evaluation methods (MRI, 
EEG, and FDG-PET) for epilepsy in Finnish Spitz dogs. 
3. To compare usefulness of MRI, EEG, and FDG-PET, to evaluate concordance 
of these modalities, and to compare different analytical methods for evaluating 
epilepsy in Finnish Spitz dogs. 
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3. MATERIALS AND METHODS 
3.1. General inclusion criteria 
Epidemiological study (I) was based on the Finnish Kennel Club database which 
contains names of all registered FSDs and contacts of the breeders, and on the Finnish 
Spitz Breeder Club (FSBC) database containing updated contacts from the dog owners. 
Dogs which participated in clinical studies (II-IV) were recruited using the FSBC 
database, collected after announcement where FSDs owners were encouraged to 
voluntarily inform about their possibility and wish to participate in clinical studies at the 
locations of Helsinki and Turku (II-IV) or close to their residence (III). The group of 
control FSDs was selected from the dogs without seizure history and no evidence of 
diseases known causing seizure-like episodes. Only FSDs with at least 2 seizure 
episodes and without any interictal neurological abnormalities and no evidence of other 
disease conditions which could cause seizures were included to the epileptic group in all 
four studies. Absence of changes in general physical and neurologic examination was 
confirmed by the European College of Veterinary Neurology diplomate or resident for 
all FSDs in all clinical studies (II-IV), performed to epileptic dogs interictally. In 
addition, absence of changes in CBC and blood biochemistry profile (II-IV), 
urinanalysis (II, IV), and CSF (II) were required for all FSDs for including studies. IE 
was defined for our studies as recurrent seizures with no underlying structural brain 
lesion or other neurologic or clinical signs, presumably being genetic. 
3.2. Animals and study designs 
General characteristics of control and epileptic FSDs included in four studies are 
presented in Table 1. 
Table 1. General characteristics of control (C) and epileptic (E) Finnish Spitz dogs 
(FSDs) included in the investigations (I-IV) 
 Study I 
C/E 
Study II 
C/E 
Study III 
C/E 
Study IV 
C/E 
Number of FSDs  1998/143 3/11 16/15 8/11 
Males 
Females 
952/86 
1046/57 
3/10 
0/1 
9/11 
7/4 
3/8 
5/3 
Mean age at examination (months) 66/81 35/64 70/74 63/72 
Mean age at seizure onset (months) NA
a
/39 NA/30 NA/40 NA/28 
a 
not applicable 
3.2.1. Epidemiology, inheritance and phenotype of epilepsy (I) 
A prospective study via questionnaires and phone interviews was designed. The 
questionnaires (5960) were sent in the years 2003-2004 to all owners of 1-10 year-old 
FSDs. Information was obtained from 2299 dogs (38.6%). Some owners also had 10-15 
years old living FSDs at home and submitted additional questionnaires about them 
(dogs were included in the study). Phone interviews (297) to the owners of all epileptic 
dogs, and when dogs’ clinical status remained unclear were planned. All dogs with 
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insufficient information (117), dogs whose owners could not be contacted by phone 
(10), whose dogs had only one seizure episode at the time of phone call (24), and whose 
dogs were younger than one year at the time of answering the questionnaire (5), were 
excluded from the study (in total 156). Any inconsistencies in the number of dogs (n) 
included in the estimation of various answers was caused by incomplete filling of the 
questionnaires or when owners were not confident about the correct answer. Finally, 
2141 FSDs of which 143 were epileptic were included in the study. Epilepsy prevalence 
was calculated for the FSDs who were alive at the time their owners answered the 
questionnaire (2069 dogs in total, 111 epileptics). For pedigree analysis, closely related 
families with multiple epileptic dogs over several generations were selected. IE was 
diagnosed by a veterinarian in 73 of the 141 (51.8%) dogs, based on seizure history in 
all of the 73 dogs and in addition by CBC and serum biochemistry in 35 (27.8%) dogs 
(Table 2). Seizure types were classified as SF, CF, focal with secondary generalization, 
secondary generalized with unknown onset, and primary generalized.  
3.2.2. Structural brain imaging with MRI (II) 
Control dogs (1 dog was excluded from the initial control group because of seizure 
episode 1 year later) and FSDs with focal epileptic seizures were studied with MRI for 
the detection of structural brain changes. EEG was recorded on the previous day and 
CSF samples from the cerebellomedullary cistern were collected immediately after MRI 
examination in all dogs (Table 1, 2).  
3.2.3. Cerebral electrical activity measured with EEG (III) 
EEG in healthy and FSDs with epilepsy was recorded (1 dog was excluded from the 
initial epileptic group of 16 FSDs because of concurrent diabetes mellitus). A special 
tour was arranged in 2005 to record EEGs from 18 FSDs situated all around Finland 
(Table 1, 2).  
3.2.4. Imaging cerebral glucose metabolism with FDG-PET (IV) 
FDG-PET in FSDs with and without focal epilepsy was examined (Table 1, 2). Median 
body weight for epileptic and control dogs was 14 (range, 10-19) and 12 (10-15) kg, 
respectively. Median age at seizure onset was 22 (range, 7-72) months. Median seizure 
duration and seizure frequency were 10 (range, 0.5-15) min and 3 (0.5-12) per year, 
respectively. One epileptic FSD had a seizure episode 14 h and one 24 h before PET 
examination. Four epileptic dogs were receiving treatment with antiepileptics.  
3.3. Ethical considerations 
All studies were approved by the Ethics Committee on Animal Trials at the University 
of Helsinki. 
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3.4. Questionnaire and phone interview (I) 
General information (name, registration number, gender, personality trait, weight, 
height, food type, feeding habits, living conditions, and activities) was collected from 
all the dogs. Questions about the age at seizure onset, total number of observed seizures, 
seizure frequency and severity, existence of clusters or status epilepticus, possible risk 
factors for seizure occurrence, medical work-up, diagnosis and medication were asked 
from the owners of epileptic dogs.  
Phone interviews followed 1- 2 years later. Interview focused on initial ictal signs and 
on changes in disease course and treatment. Interviewers provided dog owners with 
descriptions when needed and with additional list of categories. Specific questions were 
asked about the very beginning of the seizure episode to confirm the seizure type 
classification. The owners were asked to report changes in therapy or the course of the 
disease. The course of epilepsy was defined as stable (where the frequency and length 
of the seizure episodes remained the same), progressing (where the frequency and/or 
length of the seizure episodes was increasing or cluster episodes of status epilepticus 
had appeared), or diminishing (where the frequency and/or length of the seizure 
episodes was decreasing over time). The time period used to define the course of 
epilepsy in every affected dog started at the moment of the first seizure and ended either 
at the time of the owner’s interview (if medication had not been initiated) or at the 
initiation of epilepsy medication. The owners were asked about the appearance of 
seizures that clearly differed to detect the presence of multiple seizure types in 
individual dogs. The situations under which seizures occurred were defined as up to two 
different conditions in the same dog or randomly when the dog experienced three or 
more conditions under which seizures occurred. 
3.5. Diagnostic methods 
Diagnostic evaluations performed to control and epileptic FSDs included in four studies 
are summarized in Table 2. 
Table 2. Diagnostic evaluations performed to control (C) and epileptic (E) dogs in 
studies I-IV 
Diagnostic 
evaluations 
Epidemiology (I)  
C/E 
MRI (II)     
C/E 
EEG (III)    
C/E 
PET (IV)    
C/E 
Total           
C/E 
CBC
a 
3/35 3/11 16/15 8/11 21/41 
Chem
b 
3/35 3/11 16/15 8/11 21/41 
UA
c 
3/11 3/11 3/11 8/11 10/15 
CSF
d 
3/11 3/11 3/11 2/7 3/11 
MRI
e 
7/11 3/11 3/11 7/11 8/14 
EEG
f 
7/11 3/11 16/15 6/11 24/20 
PET
g 
7/11 2/7 4/11 8/11 8/11 
a 
complete blood count                     
e 
magnetic resonance imaging 
b 
serum biochemistry                        
f 
electroencephalography 
c 
urinalysis                                        
g
 positron emission tomography        
d
 cerebrospinal fluid                            
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3.5.1. Laboratory analyses (II-IV) 
The following laboratory analyses were performed at the Central Laboratory of the 
Department of Equine and Small Animal Medicine, University of Helsinki. CBC and 
serum biochemistry (Na, K, Ca, P, Mg, glucose, total protein, albumin, globulin, 
cholesterol, blood urea nitrogen, creatinine, total bilirubin, alanin aminotransferase, 
aspartate aminotransferase, alkaline phosphatase, and creatine kinase) were examined 
from blood samples using an automatic chemistry analyser (KONE Pro, Konelab, 
Thermo Clinical Labsystems Oy, Vantaa, Finland). Urinalysis was collected by 
cystocentesis from sedated dogs. Specific gravity, chemistry, and sediment 
examinations were performed. CSF samples, collected from the cisternal puncture in 
anesthetized dogs were analysed [total cell count (RR < 5 leuc/μl); protein concentration 
(RR < 25 mg/dl)]. Cytology was analyzed using cytocentrifuge (II, III). 
Plasma glucose was analyzed by glucose/glucose oxidase method with an Analox GM7 
glucose analyzer (Analox Instruments Limited, London, UK) at Turku PET Centre (IV). 
3.5.2. MRI (II, IV) 
MRI examinations were performed using 1.5 T Siemens Magnetom (Siemens AG, 
Medizinische Technik, Germany) and 1.5 T Picker Edge (Cleveland, OH) equipment at 
a private human hospital (Magneettimehiläinen) using standard human knee coils (II). 
Animals were under general anesthesia throughout the procedure. Dogs were 
premedicated with butorphanol tartrate (Torbugesic Vet, Fort Dodge Veterinaria SA, 
Girona, Spain) 0.2 mg/kg intramuscular (im) and atropine sulfate (Atropin, Leiras, 
Turku, Finland) 0.02 mg/kg im, 30 to 60 min before induction. Induction was performed 
with propofol (Rapinovet, Shering-Plough Animal Health, Farum, Denmark) 3-5 mg/kg 
intravenous (iv) and diazepam (Diapam, Orion Pharma, Espoo, Finland) 0.25-0.5 mg/kg 
iv to effect. Intubated dogs received oxygen through a non-rebreathing system at a rate 
of 2 L/min. Anesthesia was maintained with propofol infusion 0.3-0.6 mg/kg/min 
diluted in 0.9% saline solution. Pulse rate, respiratory rate, and end-tidal carbon dioxide 
were monitored during the procedure. Dogs were placed in the scanner in sternal 
recumbency.  
Routine T1W and T2W images in all 3 standard planes (i.e., sagittal, transverse, dorsal) 
were recorded. MPR were used instead of T1W images in 4 epileptic and all control 
dogs, reconstructed later in all 3 planes as T1W images.  FLAIR sequence was 
performed in these 4 dogs in the dorsal plane. T1W images or MPR were repeated 
immediately after bolus iv injection of gadolinium-diethylenetriaminepenta-acetate 
dimeglumine (Magnevist, Schering AG, Berlin, Germany) at 0.2 mL/kg (0.1 mmol/kg).  
Additional MRI examinations within relation to FDG-PET examinations were 
performed with 1.5T Philips Integra (Philips, Best, The Netherlands) equipment at the 
Turku-PET Centre for 4 control FSD (IV). Anesthesia with medetomidine 
hydrochloride (30μg/kg) and butorphanol (0.2mg/kg) im injection was used. 
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Approximately 30 min after tracer injection, short MRI scanning protocol (at least 
T1W-3D and T2W images in transverse plane) was started.  
MRI scans were reviewed independently by a board certified veterinary radiologist and 
a human radiologist. Only findings described by both reviewers were considered 
significant. The scans of healthy FSDs were examined first to identify any breed-
specific differences. The scans were examined for 1) asymmetry and dilatation of fluid 
spaces, 2) developmental anomalies, 3) hippocampal abnormalities (size or structure), 
4) proportions and localization of gray and white matter, 5) focal identifiable changes, 
6) presence of inflammation, and 7) other (e.g. post-traumatic) changes.  
MRI scans for study IV were reviewed by the author for absence of structural brain 
abnormalities and used for comparison with FDG-PET images. 
3.5.3. EEG (II-IV) 
EEG examinations were performed at the Small Animal Clinic of the University of 
Helsinki (II-IV) and in six veterinary private practices covering different locations of 
Finland (III), using the same equipment and study protocols. Portable EBNeuro EEG 
equipment (Galileo Be Light Peripheral Configuration, Firenze, Italy) was used to 
record EEG under medetomidine sedation (40–60 mg/kg, im). Patients were positioned 
in sternal recumbency. A method of standardized placement of EEG electrodes that 
resembled the 10 to 20 international system for humans was used. EEG was recorded in 
14-channel reference montage (F7, F3, F4, F8, T3, C3, Cz, C4, T4, P3, Pz, P4, O1, O2; 
sensitivity, 10 mV/mm; time constant, 0.3 seconds; Hf, 70 Hz; notch filter inserted; 
reference: on the ridge of the nose between the eyes; ground: caudally to the external 
occipital protuberance). Sixteen EEG needles (30-gauge 15-mm monopolar stainless-
steel needle electrodes, Bionen, S.a.s., Firenze, Italy) were inserted as subdermal active, 
reference, and ground electrodes. Impedances did not exceed 5 kV. The ECG and 
respiratory rate were recorded via the polygraphic electrodes (Bionen S.a.s., Firenze, 
Italy) (for ECG: sensitivity, 70 mV/mm; time constant, 0.3 seconds; Hf, 70 Hz; and for 
respiratory rate: sensitivity, 20 mV/mm; time constant, 0.3 seconds; Hf, 70 Hz); EEG 
recording lasted 20 minutes, after which EEG data were stored in the acquisition station 
(RST Galileo System, EBNeuro, Firenze, Italy) for subsequent analysis.  
The EEG records were visually examined (examiner blinded for dogs clinical status) in 
bipolar montage (III, IV). The sleep stage, possible normal variants, or epileptiform 
findings, without knowing the clinical status of the dogs were described. Additional 
review of EEG records was performed on referential montage to eliminate epileptiform 
patterns and artifacts from further background analysis. For all dogs, 60 replications of 
2-second artifact-free epochs were randomly selected from the entire EEG to analyze 2 
minutes of recording. For epileptic dogs, unsuppressed epochs without epileptic activity 
were analyzed. Background activity was analyzed (calculated and averaged for each 
channel) with the same acquisition station, and with an integrated software program 
Fast Fourier Transform. The spectral bands of delta (0.5–4.0 Hz), theta (4.5–8.0 Hz), 
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alpha (8.5–12.0 Hz), and beta (12.5–30.0 Hz) were calculated and expressed as relative 
power (%). 
The EEG records for study II were examined visually relative to clinical information (in 
referential montage). 
3.5.4. FDG-PET (IV) 
FDG-PET examinations were performed in the Turku-PET Centre. FDG was 
synthesized in Radiopharmaceutical Chemistry Laboratory from mannosyl triflate using 
a nucleophilic method. The radiochemical purity exceeded 95% in every production 
batch.  
Animal preparation and scanning procedures were performed in a quiet and darkened 
room. Before the PET examination, dogs were fasted for minimum 8 h with water freely 
available and then sedated with medetomidine hydrochloride 30 μg/kg and butorphanol 
0.2 mg/kg im injection. After 10-15 min, an iv catheter was inserted to a cephalic vein 
and blood samples for baseline glucose measurements were taken. Dogs received 
oxygen supply through the mask at the rate 2 L/min during the entire sedation period. 
Pulse rate and oxygen saturation were monitored during the procedure with a pulse-
oxymeter. For dogs 5.2 ± 1.1 MBq/kg FDG was administered iv 15-25 min after 
sedative injection. Forty min after tracer injection an additional dosage of medetomidine 
15 μg/kg and midazolam (Midazolam Hameln, Hameln Pharmaceuticals, Hameln, 
Germany) 0.2 mg/kg was injected im.  
PET imaging was performed using a brain dedicated, high resolution PET scanner 
(ECAT HRRT, Siemens Medical Solutions, Knoxville, TN, USA) (minimal spatial 
resolution in the reconstructed images 2.5 mm in the 10 cm field of view). Dogs were 
scanned in sternal recumbency using head fixation foam wedges specially designed for 
this study. Scanning was started 55 min after injection of the tracer and emission data 
were collected for 40 min. After emission scan, a 7 min transmission scan for 
attenuation correction was performed. This protocol was also used for five control dogs. 
Transmission scan was not used for the three first epileptic dogs and for the sixth 
epileptic dog (dog moved before the end of scanning). For these four dogs, attenuation 
correction model was created on the base of the transmission scanning (mu-map image) 
data set collected from one of the healthy dogs. True events were normalized, corrected 
for attenuation and scatter (Watson 2000), and then reconstructed by the iterative 
ordered subsets expectation maximization 3D algorithm (Michel et al. 2000). Images 
were reconstructed into a volume of 256 x 256 x 207 cubic voxels, size 1.81 mm
3
. 
For three control dogs the same anesthesia protocol, but dynamic FDG-PET scan was 
used. PET-scanning was initiated simultaneously with the intravenous administration of 
FDG. Total emission scan duration was 75 min. Transmission scan started immediately 
after the emission study. For all the dogs, the images were reconstructed to similar time 
frames. For all epileptics and for 3 of the healthy dogs, a 20 min long frame from the 
beginning of the scanning-period was reconstructed. 
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Visual analysis of images was performed independently by the three authors using 
image analysis software Vinci 2.56 (Max-Planck-Institute for Neurological Research, 
Cologne, Germany). The scans of healthy and epileptic FSDs were reviewed in a 
randomized blinded manner. Co-registration with T1W-3D MRI was used when needed 
for anatomical localization of the findings. Any localized or lateralized visual 
asymmetries of the glucose uptake which were visible through at least 3 slices were 
sought. Changes were considered significant when at least 2 reviewers described a 
similar finding. 
For the semi-quantitative analysis, volumes of interest (VOIs) were manually drawn 
over dorsal (coronal) slices using Imadeus Academic 1.0 software (Forima Inc, Turku, 
Finland). MRI multiplanar reconstruction 3D images were used as anatomical reference. 
Bilateral VOIs covered frontal, temporal, parietal, and occipital cortexes, hippocampus, 
nucleus caudatus, caudal colliculus, thalamus, and cerebellum. Maximal symmetry of 
bilateral VOIs and homology between individuals was sought after. Additionally 
unpaired VOIs to white matter, to gyrus cinguli and vermis cerebelli were drawn. For 
further analysis, VOIs were normalized against the white matter value of the same dog. 
Standardized uptake values (SUVs) were calculated as a ratio of tissue radioactivity 
concentration (kBq/g)/ injected FDG dose (MBq) and divided by body weight (kg).  
The left-right asymmetry index (AI) for all pairs of homologous VOIs was used to 
estimate lateralization of changes. In the formula AI= (L-R) x 100/([L+R]/2)% positive 
AI indicated reduced glucose metabolism in the right and negative in the left side VOI. 
3.6. Statistics 
Study I A mixed logistic regression model was used for analyzing factors associated 
with epilepsy. A stepwise backward elimination procedure was used for fitting the final 
model. For dogs character description, a binary factor was used (lively or not) because a 
small number of dogs were characterized differently than lively (phlegmatic, depressed 
or nervous). The age of the dogs was adjusted for the probability to have epilepsy which 
increases with age including dogs age and quadratic term of age into the model. The 
dogs sire was used as a random factor to account for the clustering effect. Univariate 
analysis was used for evaluating different factors and epilepsy phenotype characteristics 
associated with disease progression (progressing or stable) or with generalized form of 
seizures (generalized group included all seizures with the generalized phase of seizure) 
in diseased dogs. For pairwise comparisons in multi-categorical factors, Bonferroni 
adjustment was used. Results from logistic regression analyses are presented as odds 
ratios (OR) with 95% confidence intervals (CI).  
The heritability of epilepsy was evaluated by the variance component estimation with 
restricted maximum likelihood estimation method by using VCE 6.0 software 
(Neumaier & Groenevald 1998, Groenevald et al. 2008). The linear model used 
included epilepsy status as the dependent variable, sex, hunting (used or not), 
personality trait (lively or not), living condition (only outdoors or not), age, and 
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quadratic term of age as fixed factors. Random factors were additive genetic effect 
(using dog dam, sire and sire sire information) and error term. Heritability was 
calculated by dividing the additive genetic variance by the sum of additive genetic 
variance and residual variance. 
Study III Gaussian distribution of the study groups was evaluated using Kolmogorov-
Smirnov technique for normality, and the Wilk-Shapiro technique of the quantitative 
EEG data. Ordinary analysis of variance (ANOVA), in combination with the pairwise t-
test for multiple comparisons with Bonferroni p correction, was applied first to evaluate 
the significance of differences. Bartlett’s test was used to evaluate the differences 
among the standard deviations. The Kruskal-Wallis test (nonparametric ANOVA) and 
Dunn’s Multiple Comparison test were used for reevaluating the significance of 
differences among the groups for delta, theta, and beta bands. Multivariate analyses 
were performed by using the multiple logistic regression technique with EEG activity 
type as the dependent variable, and age, sex, weight, heart rate, medetomidine dosage, 
number of drug administrations, and time from initial injection to the beginning of 
recording as the independent variables.  
All data were expressed as mean ± standard deviation. For all electrodes of a single 
animal, the relative power mean value was calculated. The values of each derivation 
were averaged for every study group (14 derivations) and used later to calculate single 
values for every dog group. For statistical analysis, the epileptic group was divided into 
two subgroups: dogs with epilepsy without treatment (10 dogs) and dogs with epilepsy 
under phenobarbital treatment (5 dogs). 
Study IV To compare epileptic and control FSDs` age and weight Wilcoxon rank-sum 
test were used and Fisher exact test was used to compare sex distribution of those 
groups. Fisher exact test was used to compare associations between epileptic status and 
visual findings of asymmetry in different brain regions. To compare differences 
between epileptic and control FS dogs in AI index values, SUV and white matter 
normalized values by brain region non-parametric Wilcoxon rank-sum test were used.  
Above described statistical analyses were carried out using Stata versions 9 (I), 11.0 
(IV) (Stata Corporation, TX, USA), and R version 2.2.1. (III) (Development Core Team 
2005, Vienna, Austria).  
The level of significance in all studies was set at 5% (P < 0.05). 
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4. RESULTS 
4.1. Epidemiology, inheritance (I) and phenotype (I-IV) of epilepsy  
The prevalence of suspected IE in the Finnish population of FSDs was 5.36% (95% CI 
4.43-6.43). Epilepsy was more prevalent among males than females (OR 1.7, 95% CI 
1.2-2.5; P = 0.006). Other personality traits (phlegmatic, depressed, nervous) were more 
associated with IE than was the characteristic of lively (OR 5.9, 95% CI 2.9-11.7; P < 
0.001). Being used in hunting and living exclusively outdoors were negatively 
associated with epilepsy (OR 0.5, 95% CI 0.3-0.9; P = 0.01 and OR 0.6, 95% CI 0.4-
0.9; P = 0.01, respectively). General data used in epilepsy risk factor analyses are 
presented in Table 3. 
Table 3. General data of healthy and epileptic Finnish Spitz dogs (FSDs) in epilepsy 
risk factor analysis. 
Factor Healthy FSDs 
(n = 1998) 
Epileptic FSDs 
(n = 143) 
Median age (IQR
a
) (months) n = 1998
b 
62   (38 & 87) 
n = 143
b 
76    (58 & 111) 
Median height (IQR) (cm) 46   (43 & 48)     
n =1423 
45.5 (43 & 48)   
n = 76 
Median weight (IQR) (kg) 12   (10 & 14)  
n = 1477 
13    (12 & 15)   
n  = 95 
Gender, n (%; 95% CI
c
) 
     Male  
        Castrated 
     Female 
        Neutered 
n = 1998 
952   (47.6; 45.4-49.9) 
37     (1.9; 1.3-2.5) 
1046 (52.4; 50.1-54.6) 
50     (2.5; 1.9-3.3) 
n = 143 
86   (60.1; 51.6-68.2) 
5     (3.5; 1.1-8.0) 
57   (39.9; 31.8-48.4) 
3     (2.1; 0.4-6.0) 
Feeding times per day,  n (%; 95% CI) 
     Once 
     Twice 
     Three times 
n = 1974 
792   (40.1; 38.0-42.3) 
958   (48.5; 46.3-50.8) 
224   (11.3; 10.0-12.8) 
n = 142 
44    (31.0; 23.5-39.3) 
67    (47.2; 38.8-55.7) 
31    (21.8; 15.3-29.5) 
Food type,  n (%; 95% CI) 
     Commercial food 
     Home food 
     Mixed-food 
n  = 1913 
531   (27.8; 25.8-29.8) 
282   (14.7; 13.2-16.4) 
1100 (57.5; 55.2-59.7) 
n = 134 
35    (26.1; 19.0-34.4) 
16    (11.9; 7.0-18.7) 
83    (61. 9; 53.2-70.2) 
Used in hunting,  n (%; 95% CI) n = 1983 
1784 (89.9; 88.6-91.3)  
n = 142 
110  (77.5; 69.7-84.0)  
Other animals at home,  n (%; 95% CI) n = 1977 
1151 (58.2; 56.0-60.4)  
n = 142 
81    (57.0; 48.5-65.3)  
Personality trait,  n (%; 95% CI) 
     Lively 
     Phlegmatic 
     Depressed 
     Nervous 
n = 1984 
1941 (97.8; 97.1-98.4) 
5       (0.3; 0.1-0.6) 
10     (0.5; 0.2-0.9) 
28     (1.4; 0.9-2.0) 
n = 139 
122 (87.8; 81.1-92.7) 
2      (1.4; 0.2-5.1) 
4      (2.9; 0.8-7.2) 
11    (7.9; 4.0-13.7) 
Living,  n (%; 95% CI) 
     Only outdoor 
     Outdoor and inside 
n =1980 
1446 (73.0; 71.0-75.0) 
534   (27.0; 25.0-29.0) 
n = 133 
80    (60.2; 51.3-68.5) 
53    (39.8; 31.5-48.7) 
a
 25% & 75% quartiles                                                                                                
c
 confidence interval 
b
 number of animals where information about evaluated factor was available 
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The heritability estimate of suspected IE in FSDs was based on the linear variance 
component model and was 0.22 (SE = 0.07). The median inbreeding coefficient in 
epileptic dogs was 9 (25% & 75% quartiles: 8 & 11; range: 7-24) and that of healthy 
dogs was 9 (7 & 11; range: 5-57). The inbreeding coefficient was not associated with 
epilepsy. The segregation of IE in the sample of FSDs pedigrees is presented in Figure 
1. 
 
□ males; ○ females. FSDs that suffered from epilepsy are marked with filled symbols (black or gray), and 
dogs with no clinical manifestation of seizure episodes are represented by white symbols. Grey-bordered 
symbols indicate 21 affected and 16 unaffected dogs, which were clinically examined. The sire and dam 
marked with * were mated twice and produced a total of 11 full siblings. Only one litter is marked on the 
pedigree. The dogs from the other litter are healthy (not shown). The sire and dam marked with # were 
mated four times and produced a total of 14 full siblings. Three of these unaffected litters are not shown. 
Figure 1. Segregation of idiopathic epilepsy (IE) in the pedigree of a sample of Finnish 
Spitz dogs.  
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The situations under which seizures occurred were stress or in connection with exercise 
(78 cases), during sleep or rest (35 cases), after eating (7 cases), and randomly (49 
cases) (total 132 dogs). Other factors possibly related to the occurrence of episodes were 
the season of the year in 25 of 124 (20.2%), time of the day in 53 of 130 (40.8%), 
weather conditions in 11 of 134 (8.2%), sexual cycle in 10 of 122 (8.2%), or other 
disease conditions in 1 of 132 dogs.  
The median age of the dogs at the onset of seizures was 3 years (25% & 75% quartiles: 
24 & 48; range: 7-120 months). The median frequency of seizures was 2 seizures per 
year (1.5 & 4; range: 0.5-48). The median duration of ictus, including initial signs, was 
12 min (7 & 22.5; range: 1.5-90 min) (n = 138). Initial clinical signs of ictus with a 
median length of 3 min (1.5 & 5.5; range: 0.5-60 min) were recognized in 87 of 127 
dogs (68.5%). These signs were recognized as behavioral (i.e. hiding without reason) (n 
= 79), automatism (i.e. repeated changing of position or licking movements) (n = 10), 
motor (i.e. weakness or tremors) (n = 17), and autonomic (i.e. vomiting) (n = 3). The 
consciousness level at the time of the initial signs was classified as normal in 20 dogs 
and impaired in 66 dogs. The median duration of the ictal signs (not including the initial 
signs) was 10 min (5.5 & 20; range 1-80 min). The most important ictal signs were 
motor (n = 123), recognized as tremors (n = 17), weakness (n = 49), tonic-clonic (n = 
40), tonic (n = 16), and clonic (n = 1). The motor signs were localized to the limbs in 59 
dogs, to the face in 3 dogs, and involved the whole body of 61 dogs. Behavioral signs 
were recognized in 20 of the 119 dogs (16.8%). Autonomic signs (n = 105) included 
salivation (n = 87), vomiting or regurgitation (n = 38), and urination/defecation (n = 
29). Automatisms were observed in 49 of 120 dogs, and they mainly involved 
coordinated paddling of all four limbs at the time of the generalized phase. The level of 
consciousness was classified in the final stage of ictus as normal in 3 dogs, impaired in 
56, and lost in 67 (126 dogs total). Postictal signs including restlessness, impaired 
responsiveness, thirst, and hunger were found in 117 of 136 dogs. The median duration 
of postictal signs was 21.3 min (25% & 75% quartiles: 5 & 75). Cluster episodes were 
present in 22 of 136 (16.2%) dogs. 
Of 141 dogs, 120 (85.1%) had focal onset seizures. Seizure episodes were classified as 
SFS in 3 dogs and as SFS with secondary generalization in 18 (12.8%) dogs. The 
seizures of 41 (29%) dogs were CFS, and the seizures were CFS with secondary 
generalization in 58 dogs (41.1%). The seizures of 1 dog were primary generalized, and 
the seizures of 10 dogs were generalized but with unknown onset. Seizures in 10 dogs 
remained unclassified. Additionally, 24 of 128 (18.8%) dogs experienced seizure 
episodes of multiple seizure types. These episodes usually had similar onsets with or 
without generalization. Differently classified episodes were SFS in 3 dogs, CFS in 13 
dogs, and CFS with secondary generalization in 8 dogs.  
The only factor associated with a progressive course of epilepsy was the presence of a 
generalized phase of seizure (OR 2.6, 95% CI 1.0-6.3; P = 0.039). General data 
regarding the factors associated with focal versus generalized seizures are presented in 
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Table 4. The age at seizure onset was strongly associated with the seizure generalization 
(P = 0.009), and a generalized phase of seizure occurred more frequently when the first 
seizure occurred during the first 3 years of life (OR 2.7, 95% CI 1.3-5.8). When 
generalized seizures (primarily or secondarily) were compared to focal seizures, they 
were more prevalent in dogs with a shorter ictal episode. Longer seizures (up to 20 min) 
tended to be focal seizures rather than generalized ictal events. Seizures longer than 20 
min tended to be generalized. This tendency was statistically significant, as 
generalization was more common with seizures lasting 1-10 min (OR 4.7, 95% CI 1.7-
13.0, P = 0.006) or seizures longer than 20 min (OR 3.4, 95% CI 1.4-8.3, P = 0.012) 
compared with seizures lasting 11-20 min.  
Table 4. Factors associated with focal versus generalized seizures in FSDs (n = 131) 
Factors Focal seizures 
 
(n = 44) 
Seizures with 
generalization  
(n = 87) 
P value 
Disease progression, n (%; 95 CI
a
) 
     Progressing 
     Stable or diminishing 
 
8 (19.1; 8.6-34.1) 
34 (81.0; 65.9-91.4) 
 
29 (37.7; 26.9-49.4) 
48 (62.3; 50.6-73.1) 
0.039 
Median (IQR
b
) age at seizure onset (months) 
Age of dogs at seizure onset, n (%; 95 CI) 
     ≤ 36 months 
     > 36 months 
40.5 (27 & 57.5) 
 
21 (47.7; 32.5-63.3) 
23 (52.3;36.7-67.5) 
30 (19 & 48) 
 
62 (71.3; 60.6-80.5) 
25 (28.7; 8.2-32.7) 
0.022 
0.009 
 
Length of seizure episode, n (%; 95 CI) 
     1-10 min 
     10.1-20 min 
      > 20 min 
 
15 (34.8; 21.0-50.9) 
20 (46.5; 31.2-62.3) 
8   (18.6; 8.4-33.4) 
 
41 (47.1; 36.3-58.1) 
16 (18.4; 10.9-28.1) 
30 (34.5; 24.6-45.4) 
0.004
* 
0.006
** 
 
0.012
**
 
Feeding times per day, n (%; 95 CI) 
     Once 
     Twice 
     Three times 
 
9   (20.4; 9.8-35.3) 
19 (43.2; 28.3-59.0) 
16 (36.4; 22.4-52.2) 
 
31 (35.6; 25.6-46.6) 
40 (45.9; 35.2-57.0) 
16 (18.4; 10.6-28.1) 
0.052
* 
 
0.196
** 
0.034
**
 
Used in hunting, n (%; 95 CI)  
     Yes 
     No 
 
29 (65.9; 50.1-79.5) 
15 (34.1; 20.5-50.0) 
 
71 (82.6; 72.9-89.9) 
15 (17.4; 10.1-27.1) 
0.036 
 
a
 confidence interval 
b 
25% & 75% quartiles 
* P value for multi-categorical factor significance by the Wald test. 
** P value of pairwise comparison with factor category without p value and corrected with the Bonferroni 
adjustment coefficient. 
Another factor correlated with seizure generalization was the number of feeding times 
per day. Epilepsy generalization was more frequent among dogs that received food once 
per day than among dogs that ate 3 times per day (OR 3.4, 95% CI 1.2-9.5; P = 0.034). 
Similarly, dogs fed once per day had a higher risk of generalized seizures than dogs that 
ate twice per day. However, this was a non-significant trend (OR 2.1, 95% CI 0.9-5.1; P 
= 0.196). In addition, hunting was associated with seizure generalization (P = 0.036), as 
dogs used for hunting had a higher risk of seizure generalization than non-hunting dogs 
(OR 2.4, 95% CI 1.1-5.6). 
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Further, 42 of 137 (30.7%) epileptic dogs received epilepsy medication, and 
phenobarbital was the predominant drug. Treatment was considered to be effective in 30 
of 38 (78.9%) dogs (a ≥ 50% decrease in seizure frequency), independently of whether 
the seizures were focal or secondarily generalized. Most of the treated dogs had a 
generalized phase of seizure. Fatigue, increased drinking and eating, whilst nervousness 
and aggressiveness were the possible side effects of the treatment: reported for 16 of 39 
(41%) dogs by their owners. Treatment was believed to have a negative influence on the 
hunting ability of 1 treated dog. Eight out of 33 (24.2%) owners of hunting epileptic 
dogs claimed that antiepileptic medication would have a negative influence on the dogs’ 
hunting ability, although their dogs had never received any epileptic medication. This 
reflects the general opinion among the hunting community in Finland. Treatment with 
diazepam at the time of seizure was used in 13 (9.2%) dogs. 
All epileptic FSDs from study II had focal seizures (10 CFS and 1 SFS). Seizures 
started with focal motor signs in 8 and with sudden behavioral change in 3 dogs. One 
dog had CFS without generalization or primarily generalized episodes. Other focal 
seizures had secondary generalization. One dog had SFS as a second seizure type. Mean 
seizure length was 9 (range: 1-30) min and length of interictal period 4 (range 0.25-12) 
months. 
All epileptic FSDs in study III had focal seizures (11 CFS and 4 SFS) with secondary 
generalization. Mean seizure length was 10 (range: 1-30) min and length of interictal 
period 5 (range 0.25-12) months. 
All epileptic FSDs in study IV had focal seizures (10 CFS and 1SFS) with secondary 
generalization and with the mean seizure length of 7 (range: 0.5-20) min and length of 
interictal period 4 (range: 0.7-12) months. 
4.2.  MRI (II, III, IV) 
No MRI changes were noted, except in 1 dog. Mild contrast enhancement after 
gadolinium injection was observed in the right parietal cortex of this dog. The size of 
the lesion was 5.5 mm, and it was visible in 2 transverse slices. No changes were 
present in a repeated MRI examination of this patient performed 13 months later.  
Additional MRI scans for study IV revealed no abnormalities. 
4.3. EEG (III, II, IV) 
At the visual examination of the EEG recordings, all dogs exhibited a high-voltage low-
frequency background activity. Background activity was superimposed with spindles or 
focal beta bursts in 8 control dogs and 5 dogs with epilepsy and with benign 
epileptiform transients of sleep in 13 control and 8 epileptic FSDs. Paroxysmal 
epileptiform activity was observed in three dogs with epilepsy, and it was characterized 
by spikes, polyspikes, and spike and slow wave complexes in posterior-occipital 
derivation in all of them (Figure 2 A, B). One dog with epilepsy exhibited periodic delta 
activity at right temporal localization, and, in two dogs, delta rhythms were diffuse. One 
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control dog exhibited midline spikes (Figure 3), and one had occipital theta rhythms. No 
significant correlations by multivariate analyses between EEG activity type and age, 
sex, weight, heart rate, nervousness of the patient, medetomidine dosage, number of 
drug administrations, and time from initial injection to the beginning of recording was 
found.  
 
Figure 2. Electroencephalographic traces of an epileptic Finnish Spitz dog. (A) 
Repeated spike and slow wave complexes in bilateral occipital and parietal derivations. 
(B) Slow background activity superimposed with spike in bilateral occipital and parietal 
derivations (arrows). Recording is in bipolar montage, time constant 0.3 second, and 
high frequency filter 70 Hz; notch filter inserted. 
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Figure 3. Electroencephalographic traces of a control Finnish Spitz dog showing spikes 
in midline derivations (arrow). Recording is in bipolar montage, time constant 0.3 
second, and high-frequency filter 70 Hz; notch filter inserted. 
The results of the quantitative EEG showed a prevalence of slow rhythms (delta and 
theta) in all groups, whereas fast rhythms (alpha and beta) were poorly represented. All 
data, but theta band relative power for epileptic FSDs without treatment were sampled 
after Gaussian distribution and passed a normality test. Differences among standard 
deviations for mean relative power of delta and alpha bands were significant (Table 5) 
The control dogs showed significantly less theta and beta activity (P < 0.01) on their 
EEG than did the common group of dogs with epilepsy, although the only significant 
difference between healthy dogs and dogs with untreated epilepsy was in the alpha band 
(P < 0.001) (Table 6). Phenobarbital treatment increased alpha, beta (P < 0.001), and 
theta (P < 0.01), and decreased delta (P < 0.001) bands compared with dogs who have 
untreated epilepsy. All dog groups had similar characteristic relationships for theta and 
beta frequency bands. 
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Table 5. Results of mean relative power of electroencephalography background activity 
bands for different groups of Finnish Spitz dogs expressed as mean and standard 
deviation (SD). 
Group Delta band mean 
(± SD) 
Theta band mean 
(± SD) 
Alpha band mean 
(± SD) 
Beta band mean  
(± SD) 
FSE
a 
82.33 (1.10) 10.46 (0.70) 3.79 (0.34) 2.92 (0.20) 
FSENT
b 
83.37 (0.90) 9.97 (0.65) 3.46 (0.27) 2.73 (0.17) 
FSEPh
c 
80.24 (1.74) 11.46 (1.00) 4.44 (0.55) 3.30 (0.29) 
FSC
d 
82.79 (0.61) 9.64 (0.27) 4.08 (0.18) 2.66 (0.14) 
a 
Finnish Spitz dogs with epilepsy  
b
 subgroup of Finnish Spitz dogs with epilepsy without treatment 
c 
subgroup of Finnish Spitz dogs with epilepsy on phenobarbital monotherapy 
d
 control Finnish Spitz dogs 
Table 6. Significance in electroencephalography background activity bands between 
different groups of Finnish Spitz dogs. 
 Delta relative 
power (%) 
Theta relative 
power (%) 
Alpha relative 
power (%) 
Beta relative 
power (%) 
FSE
a
 verus FSC
d 
NS
e 
** NS ** 
FSENT
b
 versus FSEPh
c 
*** ** *** *** 
FSENT versus FSC NS NS *** NS 
FSEPh versus FSC ** *** NS *** 
a 
Finnish Spitz dogs with epilepsy 
b 
subgroup of Finnish Spitz dogs with epilepsy without treatment 
c 
subgroup of Finnish Spitz dogs with epilepsy on phenobarbital monotherapy 
d 
control Finnish Spitz dogs;  
e
 not significant, significance level P > 0.05 
* significant difference between compared study groups in the level of P < 0.05 
** significant difference between compared study groups in the level of P < 0.01 
***, significant difference between compared study groups in the level of P < 0.001 Significance levels 
for delta, alpha, and beta bands were examined with nonparametric tests. Significance level for theta band 
was evaluated with parametric test. 
Interictal epileptogenic activity in EEG recordings of study II was focal in 7 and 
generalized in 4 dogs. Focal activity tended to generalize or spread contralaterally in 7 
dogs. The epileptic activity occurred in the anterior right hemisphere (1 dog), the central 
posterior right hemisphere (2 dogs), the posterior areas (2 dogs), the left temporal area 
(1 dog), or the posterior temporal derivation and the entire posterior derivation (1 dog).  
Visual evaluation revealed changes in the EEGs in 4 epileptic and 3 control dogs 
included to the FDG-PET study (IV). Findings were classified as paroxysmal 
epileptiform activity in 4 dogs (3 epileptics and 1 control FSD) and epileptiform with 
uncertain clinical relevance in 2 control and 1 epileptic FSD (midline spikes, Figure 3). 
 Results  
45 
 
4.4. FDG-PET (IV) 
There were no statistical differences between the study groups by sex, age, and weight. 
Visual evaluation revealed 17 significant findings in 13 dogs. Five findings were agreed 
by three examiners and 12 findings by two examiners. Six dogs had no visible changes 
(validated in 3 dogs by three and in 3 dogs by two examiners). Findings in epileptic and 
in control FSDs were classified as mild (5; 3) or obvious (6; 3), respectively. FDG 
uptake abnormalities/asymmetries appeared in 9 epileptic (82%), and in 4 control FSDs 
(50%), some findings involved multiple brain regions.  
Epileptic and control dogs had findings in the occipital (7 and 0 dogs; Figure 4.), lateral 
temporal (3 and 3 dogs), frontal (3 and 1 dog), parietal cortex (2 and 3 dogs), caudal 
colliculum (2 and 2 dogs), cingulate gyrus (1 and 0 dog; Figure 5.) and in the nucleus 
caudatus (1 and 0 dog). No visual findings were found in thalamus or in cerebellum. 
Abnormalities were most often considered to be hypometabolic foci. As an exception, 
one dog which had a seizure episode 24 h before PET examination showed 
hypermetabolism in the gyrus cinguli. Four out of 8 healthy and 2 out of 11 epileptic 
dogs had no findings. Visual asymmetry in the occipital cortex was significantly 
associated with epileptic status (P = 0.013).  
The regional AI between the control and epileptic dogs did not differ significantly. The 
AI varied in the control dogs from 0.01 to 2.7 in the cortical regions, from 0.07 to 1.8 in 
the nucleus caudatus, 0.19 to 1.11 in the thalamus, and from 0.15 to 1.65 in the 
cerebellum when AIs from the dogs with visual findings were excluded. The highest 
asymmetry indexes were seen in the caudal colliculus (2.42) in the control dogs. The 
maximal AI for the hypometabolic cortical regions in the epileptic dogs varied from 0.5 
(direction not in agreement) to 0.71 (consensual direction with visual findings). Overall, 
in 22 of the 28 (14 of 19 in epileptic dogs) areas of visual findings, the direction of AIs 
agreed with the side of visual finding. All four dogs (two epileptic and two control 
dogs) with visual asymmetry findings in the caudal colliculus also had the highest AI in 
that region (from 2.7 to 4.34). 
The highest relative uptake of FDG was in tectum (caudal colliculus) and nearly as high 
an uptake was found in all cortical areas and in the nucleus caudatus. The lowest uptake 
was in the cerebellar hemispheres and paraventricular white matter, with the exception 
of cerebellar vermis which had comparable uptake with the hippocampus. The epileptic 
dogs had significantly lower SUVs in numerous cortical regions (frontal, parietal, 
temporal, occipital lobes), cerebellum and hippocampus compared to the control dogs 
(P ≤ 0.05). White matter normalized values did not reveal any significant difference 
between epileptic and control group. 
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Figure 4. Dorsal plane of FDG-PET (on the left), MRI multiplanar reconstruction image 
(in middle), and fused FDG-PET and MRI of the Finnish Spitz dog with epilepsy 
representing decreased glucose uptake in the left occipital lobe. On the left side of 
figure is in the rainbow scale FDG-PET activity bar. 
  
Figure 5. Fused FDG-PET and MRI (in transverse, dorsal, and sagittal plane starting 
from the left) of the Finnish Spitz dog with epilepsy representing postictal increased 
glucose uptake in the gyrus cinguli. 
In comparison of visual evaluation of FDG-PET and EEG examinations, in two dogs 
the EEG showed bioccipital spikes and PET showed unilateral occipital 
hypometabolism (perfect agreement on localization, Figure 4.). In one dog, EEG spikes 
were localized on the right temporo-occipital region and PET showed hypermetabolism 
in the cingulate gyrus (Figure 5).  The EEG and PET findings did not agree in any of the 
control dogs. 
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5. DISCUSSION  
5.1. Methodological issues 
5.1.1. Animals and study design (I-IV) 
IE seems not to be a distinct disease with consistent pathophysiology and genetic 
determination in dogs, but consists of multiple disease conditions. Specific seizure 
characteristics correlated to diagnostic evaluation findings are not defined for dogs. 
Therefore homogenization of a study population thorough selection of a particular dog 
breed should provide meaningful results. We selected FSDs with epilepsy as study 
subjects. Motivated and cooperative dog owners are an ultimate presumption for 
successful clinical studies. As a consequence of selecting a hunting breed, these dogs 
might have a nervous character and could behave in an unsuspected way when handled 
by somebody other than the owner. Therefore protocols of diagnostic evaluations used 
in our studies should be universally adaptable for different types of dog breeds. 
Patient selection is an important issue when examining IE. As no gold- standard method 
to confirm healthy or epileptic status in dogs exists, evidence of seizure history carries a 
crucial role when selecting patients. FSDs are kept predominantly outside and are under 
direct observation of their owners 25% to 50% of the time. Because of low seizure 
frequency in FSDs, seizures could occasionally occur without owners noticing them. 
Owners of the FSDs do pay close attention to their dogs, however, spending time with 
them during some periods (ie. during hunting season) around the clock. Seizures with 
long duration increase the likelihood of recognizing signs related to seizures (pre-ictal, 
ictal or, post-ictal signs). A concern regarding control dogs in the MRI study (II) may be 
that the dogs were young (Table 1.). This is not suspected to interfere with the study 
results, however. In addition, as these dogs also participated in other clinical studies 
where they were followed-up for many years without evidence of seizures (1 dog was 
excluded from the initial control group of MRI study because of seizure onset 1 year 
later). All owners of control dogs (I-IV) were instructed to contact researchers if 
seizures were witnessed in their animals. Although we cannot completely exclude that 
an epileptic dog was erroneously included as a healthy control, the possibility that it 
would be a dominant trend interfering with the common findings in multiple control 
dogs is considered highly unlikely.   
The prospective epidemiological investigation (I) was designed to cover the largest 
possible FSD population in Finland. Therefore the questionnaires were sent to all 
owners of FSDs in Finland (age range 1-10 years) whose contacts were available. Life 
span for FSDs is suspected to range from 10 to 13 years, but we were not able plausible 
to validate information older than 10 years. Cumulative occurrence of epilepsy should 
be highest within older dogs, but as our database included some dogs up to 15 years of 
age, the population curve followed a normal distribution. The aim was to mimic the 
natural population of FSDs in Finland in the prevalence study. To use a randomized 
design for an epidemiological study would be optimal for larger populations, but would 
lead to a remarkable decrease in this study sample which contradicts with one of the 
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aims, to collect information about as many new epileptic FSDs as possible. Standards 
for epidemiologic studies and surveillance of epilepsy for humans are proposed by the 
ILAE (Thurman et al. 2011). Such criteria are seldom applied for epidemiological 
studies of epilepsy in dogs (Berendt et al. 2002).  
Actual randomization of patients for clinical studies was not used, although some 
randomness occurred when dog owners volunteered to clinical studies. The majority of 
the FSDs population is located in Northern Finland whereas MRI and FDG-PET 
examinations were performed in Southern or Southwestern parts of Finland (500-1200 
km distant). Therefore patients situated closer to examinations were more frequently 
included, as their owners were more likely able to participate in clinical studies. It could 
be argued that results of our clinical studies are therefore not reliably representative of 
all epileptic FSDs. However, as study populations (I-IV) had similar general 
characteristics (Table 1) and total amount of clinically examined epileptic FSDs reached 
approximately 20% (Table 2) from the living epileptic FSDs, and results of different 
diagnostic modalities were accordant, hereby findings should most likely reflect 
different aspects of epilepsy in FSDs as reliable. Owners of control dogs having some 
epileptic relatives had clearly higher motivation to participate. Therefore some clinical 
findings in control dogs might reflect close genetic relationship to epileptic dogs. 
Further, special selection of control patients from the bloodlines with low incidence of 
epilepsy or reinterpreting current data within the light of results from genetic studies 
would be of great interest.  
Visual evaluation of EEG (III, IV) and FDG-PET (IV) was performed under conditions 
where reviewers were blinded for the animal’s clinical status. It is surprising that our 
EEG study has been first and only which has applied blinding, despite so many 
controversies related to that topic in veterinary medicine. A rough discrepancy of 
diagnostic yield by EEG was found, not only for epileptic FSDs (III) and what has been 
reported previously from other dog breeds, but also for FSDs depending whether the 
reviewer was blinded (III, IV) or not (II). Randomization and blinding was thus also 
applied for visual evaluation of the FDG-PET images (IV).  
5.1.2. MRI (II) 
Although MRI allows diagnosis of various cerebral pathologies in vivo with high 
sensitivity, changes are not seen in a considerable number of canine patients with 
seizures. Whilst high-field MRI examinations are routinely employed for epileptic 
human patients (Neuroimaging Subcommission of the ILAE 2000), low-field 
examinations, remain the principal approach used in veterinary medicine: despite the 
fact that improved spatial resolution, contrast, and shorter imaging time can be achieved 
with higher magnetic field equipment (Vaquero et al. 2010, Konar & Lang 2011). The 
application of 1.5T MRI examinations for FSDs in this study ensured the likelihood of 
detecting structural brain changes. Nonetheless, continued progress in diagnostic 
imaging techniques in human medicine suggests that the epileptogenic foci of what we 
 Discussion  
49 
 
now consider to be idiopathic may someday become visible (Kuzniecky et al. 2002, 
Casse et al. 2002).  
5.1.3. EEG (II-IV) 
Despite a promising introduction of EEG to veterinary medicine, its role has diminished 
over time, mainly because advanced diagnostic imaging methods are applied when 
symptomatic epilepsy is suspected. Nevertheless, EEG should be clearly indicated for 
animals with seizures when IE is suspected, being the only examination in everyday 
clinical use that is able to supply positive findings with this diagnosis. 
There are a number of limitations regarding the use of EEG in veterinary medicine 
(Pakozdy et al. 2012). It remains a challenge to obtain artifact free ictal/interictal 
recordings without sedation, and extensive muscles over the calvarium impair recording 
from lateral and ventral areas of the canine brain (James et al. 2011); but the 
development of radio-telemetric EEG recording techniques and new electrodes (Davis 
et al. 2011) may help to overcome these concerns in the future. Other limitations, 
related to the need for universally accepted needle placement, recording, and montages 
protocols requires urgent cooperation between institutions and specialists working in the 
field of veterinary EEG. Otherwise, data collected from canine EEG recordings will be 
fragmented and yield few benefits. Finally, veterinary doctors need to address their 
limited knowledge in the interpretation of EEG findings. This limitation will be easiest 
to eliminate through cooperation with human electrophysiologists and with emphasis on 
EEG interpretation in neurology specialty training in veterinary medicine.  
This study was the first to employ medetomidine as a solo agent for the sedation of 
epileptic dogs during EEG recording. Sedation with medetomidine, an alpha-2 
adrenergic agonist, is easy via im injection even for dogs behaving aggressively. 
Despite controversial reports about alpha-2 agonist pro- and anticonvulsive properties 
(Mirski et al. 1994, Jolkkonen et al. 1999, Miyazaki et al. 1999), dexmedetomidine, the 
enantiomer of medetomidine, is increasingly used for the sedation of pediatric human 
patients when examining EEG (Talke et al. 2007, Mason et al. 2009, Aksu et al. 2011). 
5.1.4. FDG-PET (IV) 
PET imaging of epileptic dogs has not been described previously to our knowledge. 
High resolution research tomography (HRRT)-PET scanner with high spatial resolution 
and superior to SPECT scanners (Peremans et al. 2001, van Velden 2009, Kang et al. 
2012) was used in this study to maximize the likelihood to detect changes. FDG was 
used as a PET tracer because of easy availability and because FDG has been used 
widely when examining epileptic human patients with PET. FDG-PET reflects glucose 
metabolism at the time from the tracer injection till the uptake reaches a steady-state (at 
least 20 min). Therefore making the patient feel comfortable for this time-period is 
crucial (Neuroimaging Subcommission of the ILAE 2000, Varrone et al. 2009). Taking 
into account breed selection (FSD), injecting the FDG without sedation, which would 
be optimal, was not an option and possible sedation effects were considered better than 
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non-homogeneous and hardly interpretable study data. Sedation influences brain 
glucose metabolism and blood perfusion (Veselis et al. 1997, Lee et al. 2010a, 
Schlünzen et al. 2012). However, no consistency exists between anaesthesia protocols 
and sedatives used for veterinary PET/SPECT studies (Peremans et al. 2001, Irimajiri et 
al. 2010, Lee et al. 2010a, 2010b, Hansen et al. 2011, Waelbers et al. 2011, 2012,). 
Combined medetomidine, butorphanol, and midazolam sedation was used in this study, 
when initial sedation was given prior to tracer injection. Data is lacking, however, 
regarding the use of such combined sedation protocol for functional imaging studies; 
but a quantitative EEG study in dogs showed no significant differences between low 
dose medetomidine and combined medetomidine-butorphanol-midazolam sedations 
(Itamoto et al. 2002). Therefore we expect that the influence of sedation on global 
cerebral glucose utilization was mainly determined here by medetomidine (increased 
metabolism), but similarly for all dogs examined. No statistical difference on SUVs was 
found when epileptic dogs with and without antiepileptics treatment were compared, as 
has been supposed in humans (Casse et al. 2002). 
Because FDG-PET has not been previously applied for canine epileptic patients, the 
main goal was to define visual findings of glucose hypometabolism, through a method 
that was not highly observer-dependent. Therefore 3 examiners with different 
backgrounds (veterinary radiologist, human children epileptologist with FDG-PET 
experience, and a scientist working with small animal PET imaging) were used. There 
was complete agreement (3 examiners) on 5 findings and partial (2 examiners) 
agreement on 12 findings. Despite a large total number of non-confirmed findings (22), 
single evaluators detected findings consensual with other evaluators more frequently. 
Therefore changes in cerebral glucose uptake can be detected by visual evaluation of 
canine FDG-PET images with reasonable consistency, however it is crucial to avoid 
over-interpretation of minor changes in cerebral FDG uptake. Nonetheless, in clinical 
patients, findings of FDG-PET should be interpreted in the context of the clinical 
picture and results compared with findings from other diagnostic modalities. 
Although the PET scanner was used here with high spatial resolution, fusion with the 
anatomical imaging methods would improve detection of fine anatomical structures 
(Peremans et al. 2001, Irimajiri et al. 2010, Lee et al. 2010, Hansen et al. 2011, Kang et 
al. 2012). Unfortunately, for technical reasons, it was not possible here to apply fusion 
of 1.5T MRI and HRRT-PET images for all of the dogs and to draw VOIs on the MRI. 
The VOIs were drawn with maximal inter-individual similarity and bilateral VOIs were 
done symmetrically and not following possible visual findings of FDG-PET. VOIs 
covered the maximal volumes of the selected brain structures. The relatively low 
sensitivity of semi-quantitative methods compared to visual findings in this study is 
largely related to the ROI defining method. To draw ROIs to the template as described 
for SPECT (Peremans et al. 2003) would be another option to diminish influence of 
examiner. However, epilepsy syndromes have seldom well characterized suspected 
homologous epileptic foci in dogs. Therefore escaping visual analysis and concentrating 
only on quantitative measuring defined by a template is likely to mask possible findings 
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on an individual basis. To draw ROIs strictly to the hypometabolic region was not 
sought after in the scope of this study and the question of how much a hypometabolic 
region can differ from the cerebral cortex with normal function between control and 
epileptic dogs unfortunately remains unanswered.  
To improve comparison of SUV between different studies and individuals, the relative 
SUV ratio (where the regional SUV is normalized with SUV of the whole brain, with 
white matter, cerebellar, or brainstem regional activity) can be performed (Koivunen et 
al. 2008, Berti et al. 2012, Kang et al. 2012). In order to also reveal global or extensive 
differences in the glucose uptake of epileptic dogs, normalized VOI values with the 
regional activity of the white matter (minimal uptake) were used. We considered it 
likely that normalization of SUV with the global cerebral activity which has been 
reported for healthy dogs examined with FDG-PET (Kang et al. 2012) would mask 
regional changes to be higher. 
5.2. Epidemiology, inheritance and phenotype of epilepsy in FSDs (I) 
Epileptic seizures are considered to be a response of the brain to a large variety of 
stimuli. Genetic factors that play an important role in the development of IE may 
influence the individual basic level of epileptogenicity. These factors may also be 
causative or influence the moderation of the disease development. (Lüders et al. 2009) 
A complex pattern of inheritance such as polygenic recessive or autosomal recessive 
with incomplete penetrance seems to fit best with the heritability estimate of 0.22 in 
FSDs obtained in our study. Even if the first pedigree analysis supported the hypothesis 
of an autosomal recessive mode of inheritance the high incidence of IE in many litters 
could also be explained by a high homozygosity level in this dog breed. We believe that 
using pedigree drawing or segregation analysis of the general non-pre-selected breed 
population makes a difference in inheritance estimates. In pedigree analysis, litters were 
found with several epileptic littermates, but some bloodlines also completely lacked 
epileptic dogs. Therefore, an IE prevalence of 5.36% in the Finnish population of FSDs 
serves as a general estimate and can differ significantly depending on the bloodline. 
Moreover, initial results from genetic study indicate that no single locus is clearly 
related to epilepsy in FSDs. This finding agrees with veterinary and human literature, 
where idiopathic epilepsies have been suggested frequently to have a complex genetic 
basis (Srenk et al. 1994, Kathmann et al. 1999, Heron et al. 2007, Dibbens et al. 2007). 
In addition to issues with study design, some other factors may influence the estimate of 
epilepsy prevalence. Although the owners of all dogs were encouraged to complete a 
questionnaire regardless of the clinical disease status of the dogs, were considered the 
owners of epileptic dogs less likely to respond. Many dog owners are ashamed about 
epilepsy in their animals, although this attitude is changing slowly. The episodic nature 
of epilepsy facilitates this denial. In any case, based on recent literature, the observed 
prevalence estimate for IE in FSDs seems to be clearly higher than that of the general 
dog population (0.6%) (Kearsley-Fleet et al. 2013), but not reaching the prevalence (18-
33%) reported from some pedigrees with a high accumulation of epilepsy (Casal et al. 
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2006, Berendt et al. 2009). Caution should be used when comparing prevalence 
estimates, however, due to inconsistency in the study populations or in methods used in 
veterinary studies. 
A statistically significant predisposition for epilepsy was found in male FSDs, in that 
the incidence of epilepsy in males was 1.7 times higher than that of females. The 
predisposition of males for IE is not reported for all dog breeds, however results of one 
study suggests that male dogs overall might be at a higher risk for epilepsy (Kearsley-
Fleet et al. 2013) and FSDs appear to share this general predisposition. In addition, the 
pedigree data presented here demonstrates that IE in FSDs appears not to be sex-linked, 
as was supposed for beagles (Bielfelt et al. 1971).  
Results presented here indicate that some personality traits such as being phlegmatic, 
depressed, or nervous could be risk factors for IE in FSDs. These personality traits were 
5.9 times more often associated with IE than lively-character. Reliable statistical 
analysis without considering all other personality traits than lively was not possible, 
however. Personality characteristics were not established for epileptic animals for two 
time points, before seizure onset and at the later course of disease in this study, which is 
a limitation. Therefore, it is impossible to distinguish whether some canine 
characteristics can predict later seizure onset or whether it is more indicative of changed 
personality caused by the epilepsy. Moreover, some bias introduced by the owners 
could not be excluded (tendency to classify non-epileptic dogs as lively). Our own 
experience with epileptic FSDs is that many of them can be described as nervous and 
often have such behavior before seizure onset. Some prove that dogs with IE may also 
experience neurobehavioral comorbidities together with the development of epilepsy 
(Shihab et al. 2011), similar to that described in epileptic humans (Hermann et al. 2008, 
Kerr et al. 2009). 
Factors found in the epilepsy risk analysis were the use of the dogs for hunting (OR 0.5) 
and the housing of dogs exclusively outdoors (OR 0.6). A likely explanation for the fact 
that healthy dogs were used more often for hunting is that dogs that started to have 
seizures were not subsequently taken on hunts. Interestingly, a significant portion of 
epileptic dogs were still being used for hunting. Historically, it has been recognized that 
some epileptic FSDs may have extremely good hunting skills (very good senses and a 
high level of alertness). Therefore, it seems that epilepsy was systematically ignored for 
many years when breeding decisions were made. The majority of FSDs still live 
outdoors in the Northern parts of Finland. Living only in outdoor conditions was 
associated with a decreased risk of epilepsy. The suggestion that outdoor dogs are 
healthier because they live in conditions which are natural for FSDs is somewhat naive. 
As the mean seizure frequency reported for FSDs living outdoors was very low, it could 
be argued that the owners may not always witness seizures in dogs living entirely 
outdoors and may therefore falsely classify them as healthy. Based on our experience, 
we suggest that the most common reason is that after the owners realize a dog is prone 
to seizures, they keep the animal under observation as much as possible. However, 
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despite reaching the level of statistical significance, biological justification could not be 
provided for any of the factors found to be associated with the occurrence of IE in this 
study, except for the genetic predisposition.   
Seizures occurred here most often (> 50%) under stressful conditions or with exercise, 
although the patient material is far too limited to offer reasonable factors to apply in the 
clinical situation. It seems that precipitating factors that trigger a seizure are 
multifactorial and may vary between individuals that many animals have more than one 
risk factor. For example 8% of FSD owners reported their dogs’ seizures were being 
triggered by the breeding sexual cycle. Nonetheless a majority of them were male dogs 
which had seizures more frequently in stress situation when female dogs were in “heat”. 
The same dogs also had other excitation triggers. In contrast, some female FSDs were 
exclusively having seizures when on “heat”. Therefore, relying more on what the owner 
observes for every individual dog could facilitate the provision of strategies for better 
control of seizure by avoiding recognized situations associated with epileptic episodes.  
This study represents the most extensive epidemiological study of IE concentrating on 
one dog breed to our knowledge: including 143 epileptic dogs and 2141 control dogs. 
Importantly, unlike previous studies, an estimate was made for the native disease 
course. The generalized phase of seizure was found to be the only significant risk factor 
for the progression of epilepsy. A clear benefit of such a disease progression predictor is 
that a generalized phase of seizure can be easily recognized by the owners. In this 
analysis, generalized phase was associated with a progressive course of epilepsy in 
every context in which it was observed, but trustworthy applicable to the phase of 
secondary generalization (91.6%). The disadvantage of ignoring the context of the 
generalized phase is that it makes harder to find a generally meaningful and adaptable 
pathophysiological explanation. Evidence provided mainly by experimental models 
such as kindling studies suggests that neuronal death depends on seizure spread and that 
propagated generalized seizures may by more harmful than partial seizures (Pitkänen & 
Sutula 2002). The presence of secondary generalized seizures has been reported to be 
one of the factors associated with a poor outcome in human epileptic patients (Jackson 
et al. 2005b). Drawing direct comparisons with our data is difficult because of the 
different preselection of patients. Our population represents patients with epilepsy, a 
genetic predisposition, no detectable brain lesions, and different seizure types. However, 
we found that secondary generalization, used as the pathophysiological hallmark of 
seizure spread within the brain, could be used to predict disease progression. This result 
seems to be biologically meaningful and is in accordance with the literature. As most 
representative seizure types in this study were CFS and focal onset seizures with 
secondary generalization, the results could be applied most reliably to dogs with IE and 
to those with similar seizure types. 
Some factors were correlated with the generalized phase of seizure. Interestingly, the 
age at seizure onset was not directly correlated with disease progression, but was 
correlated via a generalized phase of seizure. The majority of seizures were focal, 
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although secondary generalization occurred more frequently when the first episode 
occurred during the first 3 years of life. The age at seizure onset is an important factor in 
human epilepsy, and many age-specific epilepsy syndromes have been recognized. 
Among the childhood epilepsies, IE has a strong negative association with focal 
seizures (Beilmann et al. 1999). However, the exact prognosis for outcome is usually 
syndrome dependent, therefore direct comparison with this data is not sensible.  
A bimodal relationship between the seizure length and the generalized phase of seizure 
was also demonstrated here. Seizures that lasted up to 10 min were 4.7 times more 
likely to be generalized than seizures lasting 11-20 min. However, seizures longer than 
20 min were more likely (OR 3.4) to be generalized than those lasting 11-20 min. 
Evidence from human medicine can be found that this bimodal tendency might be 
related to variation of seizure type and depend on the seizure locus (Jenssen et al. 2006, 
Afra et al. 2008). It is impossible to confirm this reasoning to our results, as groups of 
all seizure types were not representative for statistical analysis and comparison.  
Regarding seizure length, it is poignant to ask at what point do seizures with a long 
duration become life-threatening. Although various criteria (seizure frequency, quality 
of life, and no need for medication) suggest a benign course of IE in FSDs, long-lasting 
seizures are classically considered to be a sign of a non-benign course of epilepsy. It is 
remarkable that seizures of up to 30-40 min were self-limiting in the FSDs and seldom 
needed special treatment at the time of the episode. In human patients, different patient 
groups may have seizures of different durations which can be considered life-
threatening; Morbidity and mortality varying for different age groups and for different 
epilepsy syndromes (Metsäranta et al. 2004). Therefore, we suggest rather a syndrome 
approach (“benign” or “not-benign”) for some canine epileptic patients, as a simple cut-
off point for the inclusion of status epilepticus to estimate seizure outcome risks. 
Several factors correlated here with the occurrence of a generalized phase of seizure, 
such as the number of meals per day and whether the dog was used for hunting. 
Consistent with a biological meaning, the correlation between the number of meals per 
day was linear. More frequent eating should stabilize the blood glucose levels. Eating 
could also be connected to the use of dogs for hunting or to excitement levels. 
Physiological hypoglycemia due to exercise in hunting dogs has previously been 
suggested as a cause of seizures (Lord et al. 1975, Leifer 1986), but hypoglycemia has 
not been proven to be an etiological factor. Blood sample analyses from a larger number 
of FSDs in connection with an ongoing study have identified no abnormalities in the 
blood glucose levels except in one dog, where hyperglycemia was associated with a 
later onset of diabetes mellitus (III). Eating just once per day and excessive physical 
activity due to hunting may cause a reduction in glucose levels and may therefore serve 
as a metabolic trigger to induce seizures of greater magnitude. However, in addition to 
constituting excessive physical activity, hunting also causes high levels of excitement 
via the activation of the autonomic nervous system.  
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Epilepsy was characterized by focal onset seizures in 85% of FSDs. This is in line with 
the latest veterinary literature where focal seizures have been reported to be the main 
seizure type for many dog breeds with IE (Licht et al. 2002, Berendt et al. 2004) and 
contradicts earlier literature that epileptic seizures in canine idiopathic (primary) 
epilepsy are generalized, whereas symptomatic (secondary) epilepsy usually is 
characterized by partial seizures (Schwarz-Porshe 1984, de Lahunta 1983, Oliver et al. 
1997, March 1998). Changes in attitude have occurred after observation of the initial 
ictal signs crucial for seizure type classification by some researchers (Berendt & Gram 
1999, Licht et al. 2002). CFS with secondary generalization was the most frequent 
seizure type (41%) detected in FSDs, similar to what is reported for many other breeds 
with IE (Licht et al. 2002, Berendt et al. 2002, Patterson et al. 2003, Berendt et al. 2008, 
Hülsmeyer et al. 2010, Gulløv et al. 2011), detailed descriptions of seizures are likely to 
differ, however. 
5.3. MRI of epileptic FSDs (II, IV) 
No brain changes were evident on the MRI of FSDs with focal onset seizures, except in 
1 dog with changes as a suspected consequence of seizures. There are only a few studies 
published in veterinary medicine about MRI findings in dogs with focal epilepsy 
(Podell et al. 1995, Patterson et al. 2003, Seppälä et al. 2012). Therefore, the opinion 
that focal epileptic seizures are caused by a focal structural brain lesion is most probably 
based on a pathophysiologic understanding of epilepsy. Focal IEs are well defined in 
human epileptology, however (Callenbach et al. 2003, Michelucci et al. 2003, Combi et 
al. 2004). The pathogenesis of some focal IEs in humans has also been described 
recently, with suggested mechanisms related to changes in the nicotinic acetylcholine 
receptor subunit or in leucine-rich glioma-inactivated factor 1 (epitempin) (Morante-
Redolat et al. 2002, Rodrigues-Pinguet et al. 2003, Combi et al. 2004). The reason why 
changes, which are expressed ubiquitously in the central nervous system, are causing 
focal epilepsy is unknown (Gourfinkel-An et al. 2004). Described changes are not 
visible with imaging methods available at this time, but can be detected with 
immunohistochemistry (Morante-Redolat et al. 2002).  
In certain canine populations, focal IE without visible MRI changes can be detected, as 
has been demonstrated here. Therefore, despite the fact that a higher prevalence of focal 
seizures has been demonstrated for dogs with symptomatic epilepsy (Pakozdy et al. 
2008), the results presented here suggest that classification of canine patients into 
idiopathic or symptomatic categories should be based on the patient’s diagnostic 
evaluation rather than on the seizure pattern alone. Furthermore, both, focal and 
generalized seizures can be idiopathic in origin. The classification of all non-lesional 
canine focal epilepsies as cryptogenic, and only generalized seizures as idiopathic, has 
been suggested (Berendt & Gram 1999); however, the use of a cryptogenic category for 
canine epileptic patients is not uniform. Although they experience focal seizures, we 
believe that the FSDs studied here best represent IE. Veterinary medicine might benefit 
from further adaptation of a new ILAE concept of classification (Berg et al. 2010), 
consequently IE in FSDs categorization into genetic epilepsy could follow.  
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MRI changes are most frequently detected in human patients with temporal lobe 
epilepsy (Casse et al. 2002), where hippocampal sclerosis is the main finding (Leherecy 
et al. 1997). No hippocampal structural changes were observed in any of the FSDs with 
focal epilepsy studied here, including the 2 dogs with EEG changes in the temporal 
area. The number of dogs was small, however, and pre-selection according to clinical 
signs and EEG pattern was not performed to state that temporal lobe epilepsy in FSDs 
does not exist. These findings do support a previous report that canine epilepsies may be 
mainly extra-temporal (Buckmaster et al. 2002), but disagree with another study which 
found lateralized hippocampal atrophy in a relatively high proportion of epileptic dogs 
examined with MRI (Kuwabara et al. 2010). The description of both focal temporal and 
focal extra-temporal epilepsies in humans with proven genetic background and no MRI 
changes is also relevant in veterinary epileptology. These results, however, show that 
identification of epileptic lesions in dogs with MRI might be even lower than in 
humans, at least for some canine populations. 
Reversible MRI abnormalities in the piriform lobe, temporal lobe or both of 3 dogs after 
seizures have been reported previously (Mellema et al. 1999). These changes 
completely or partially resolved on reevaluation. Of our dogs, only the 1 in which MRI 
changes were detected had a 2-min generalized seizure episode 3.5 h before imaging. A 
contrast-enhanced area in the right parietal lobe was noted in this dog, but these changes 
were not observed in repeated MRI 13 months later. The time period between seizure 
occurrence and MRI seems to play a critical role. Lesion identification might improve if 
examinations were done on the same day as seizure occurrence (Mellema et al. 1999). 
There was no evidence of brain changes in the other 10 dogs in our study, including a 
dog which had a 45-min period of status epilepticus 21 days before MRI examination. It 
may indicate that despite long-lasting seizure episodes, changes may not occur or may 
resolve earlier as suggested by the literature (Mellema et al. 1999). In addition to long 
duration of seizure, seizure frequency may also be an important factor in induction of 
MRI changes, but FSDs represented dogs with relatively low seizure frequency.  
5.4. EEG of epileptic FSDs (II-IV) 
5.4.1. Visual evaluation of EEG 
We described benign epileptiform transients of sleep and sleep spindles, findings well 
recognized in healthy and epileptic humans (Westmoreland 1996, Beun et al. 1998, 
Radhakrishnan et al. 1999, Zumsteg et al. 2006), in 68% of dogs included in this study 
when standard descriptions used in human neurophysiology were adapted (Noachtar et 
al. 1999). One study on humans reported 93% of sharp transients in the sleep EEG of 
healthy volunteers, with an incidence of 13% of true epileptiform discharges (Beun et 
al. 1998). Although these findings have been described previously in dogs (Klemm 
1989, Holliday & Williams 1998, Bergamasco et al. 2003), we believe that high 
occurrence of sleep transients, when epileptiform paroxysms were seldom in our study, 
could indicate that misinterpretation of these changes as true epileptic discharges is a 
relevant risk in veterinary medicine.  
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Epileptiform activity in healthy dogs is an ignored phenomenon in the veterinary 
literature. We detected midline spikes in four control dogs, and in one epileptic dog (III, 
IV). In humans, this finding is described to present epileptiform activity with uncertain 
clinical significance (Jabbari et al. 2000, Stern & Engel 2005). In addition, one control 
FSD had paroxysmal epileptiform discharges characterized by lateralized frontal spikes 
occurring simultaneously with midline spikes. Therefore, our results suggest that 
midline spikes, despite representing epileptiform activity, should be rather considered as 
a finding not characteristic for epilepsy in FSDs. Within the wider healthy human 
population, interictal epileptic discharges are present in up to 2.6% of individuals (Stern 
& Engel 2005). We found epileptiform paroxysms in 1 (5%) of the 19 control dogs or in 
4 dogs (21%) when midline spikes were included. Because of low seizure frequency in 
FSDs, some mild ictal events could be missed by their owners and dogs falsely 
classified as healthy. The control dogs with epileptiform paroxysmal activity showed no 
closer relationship to the epileptic relatives as dogs from control group on average. The 
majority of control dogs had epileptic relatives in their pedigrees at least in the 2nd or 
3rd generations. The literature on humans clearly defines the higher prevalence of 
epileptic discharges (up to 50%) on the EEG recordings of the siblings of epileptics 
(Degen et al. 1991). At present, we are unable to unequivocally answer whether 
epileptiform activity in healthy individuals may have some predictive value for the 
further development of epilepsy or could be associated with suspected polygenic 
inheritance which we have found with initial genetic investigations.  
All the epileptic dogs included in this study, according to information obtained from 
owners, suffered from focal seizures, and some with generalization. In 3 epileptic FSDs 
(1 dog with midline spikes from study IV not included) out of 17 dogs (III, IV), focal 
epileptiform activity was noted upon visual examination of the EEG records. Spikes, 
polyspikes, and spike slow wave complexes were located in the posterior and occipital 
areas in all of them. Spikes and spike slow wave pattern is recognized as a specific 
finding in many epileptic syndromes in human medicine (Stern & Engel 2005, Pillai & 
Sperling 2006). Interictal focal epileptiform paroxysms were found in the EEG of 18% 
of the epileptic FSDs (24% when dogs with midline spikes were included) and that 
contradicts the general viewpoint (Klemm & Hall 1970, Jaggy & Bernardini 1998, 
Berendt et al. 1999, Pellegrino & Sica 2004). Our study (III) was the first which pointed 
out that interictal epileptiform activity in dogs might be a less frequent finding than 
described. More recent publications have confirmed our results (Brauer et al. 2012, 
Pakozdy et al. 2012). For blinded EEG evaluation, a medical electrophysiologist was 
employed (III, IV), who strictly applied standards adapted from human medicine 
(Noachtar et al. 1999). Another EEG evaluation which detected epileptiform discharges 
in all epileptic dogs was performed by a veterinary specialist working with animals who 
was aware of dogs’ epileptic status (II). Interestingly, some findings described as 
epileptiform by a non-blinded observer and not assured by the medical 
electrophysiologist had the perfectly same location as described by FDG-PET findings. 
This might indicate some variations between EEG patterns in dogs and humans. 
However, diagnostic yield of EEG for epilepsy would also rise up to 41% for first 
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evaluator when summarizing all findings (3 dogs with changes in background rhythms 
and 1 dog with midline spikes). In humans, epileptiform activity is found in 29-55% of 
epileptic patients at first EEG examination, but can be increased up to 90% in repeated 
examination with the help of sleep deprivation, hyperventilation, or photic stimulation 
(Jabbari et al. 2000, Pillai & Sperling 2006).  
 
EEG results indicate that FSDs could experience focal IE originating from occipital or 
other posterior areas. Epileptic discharges in the occipital lobe are a relatively common 
finding in human patients, especially in children (Taylor et al. 2003), but occipital 
epilepsies account for 5-10% of all human epilepsies (Adcock & Panayiotopoulos 
2012). 
5.4.2. Quantitative EEG 
We found low delta and theta rhythms to be the dominant background activity, but 
alpha and beta bands were poorly represented in background frequency analysis of 
quantitative EEG in all FSDs. This seems to be a common EEG background pattern in 
sedated dogs (Srenk & Jaggy 1996, Itamato et al. 2001, Bergamasco et al. 2003, 
Pellegrino & Sica 2004). Slow theta and fast beta frequency bands appeared 
significantly more frequently in epileptic dogs than in control dogs, but only alpha 
activity showed statistical difference between epileptic FSDs without treatment and 
control dogs.  
An increase in the beta band was observed in a previous EEG study of healthy human 
volunteers after the oral administration of phenobarbital, and in a study of epileptic 
patients, although the results failed to reach statistical significance (Sannita et al. 1980, 
Herkes et al. 1993). A dose-dependent increase in beta and theta bands after 
phenobarbital administration has been reported in rats as well (Sato 1980). Theta 
rhythm is associated with the use of sedatives, such as barbiturates or neuroleptics, in 
humans (Stern & Engel 2005). We observed highly significant differences in all 
background bands between epileptic dogs without treatment and under medication. The 
phenobarbital influence described here agrees with the literature. Phenobarbital seems 
to increase the theta, alpha, and beta bands, and to decrease the delta band. Our results 
indicate that treatment with antiepileptic drugs should be considered when interpreting 
the data from quantitative EEG. Despite the fact that multiple findings from quantitative 
EEG in this study reached a level of significance (Table 7), applying these results to 
clinical settings might be complicated. However, in epileptic patients whose visual 
evaluation of interictal EEG remains normal, information from quantitative analysis of 
EEG might be complementary. 
5.5. FDG-PET of epileptic FSDs (IV) 
5.5.1. Visual evaluation of FDG-PET 
This is the first report where cerebral glucose metabolism in dogs diagnosed with IE is 
examined alongside FDG-PET results that indicate focal seizures in FSDs. Visual focal 
abnormality/asymmetry in FDG-PET demonstrated high sensitivity (82%) but low 
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specificity (50%) for epilepsy as several healthy dogs also had focal findings in FDG-
PET. Visual findings in FSDs involved a variety of cortical areas, but the most 
consistent focal abnormalities in the epileptic dogs were seen in the occipital region 
(with sensitivity of 64% and specificity of 100%). Therefore we summarize that visual 
evaluation of FDG-PET is able to detect hypometabolic foci in FSDs in a variety of 
cortical areas while changes in the occipital lobe are specifically related to epilepsy. In 
epileptic human patients interictal FDG-PET identifies epileptic foci related to 
neocortical epilepsy (temporal lobe epilepsy excluded), including occipital lobe 
epilepsy, in a relatively small proportion (< 50%) of patients (Casse et al. 2002, Juhasz 
et al. 2005, Lee et al. 2005). However, depending on the subgroups of patients or the 
use of a high resolution PET scanner, a remarkably higher diagnostic yield of FDG-PET 
can be expected (Hong et al. 2002, Juhasz et al. 2005). 
Cortical hypometabolic areas were also detected in half of the control dogs. Epilepsy 
not recognized by the owner in control dogs cannot completely be excluded, as they had 
close epileptic relatives. However, follow-up interviews 5 years after PET examination 
did not change the disease status of any of the control dogs. High frequency of cerebral 
hypometabolic changes in control dogs can be explained similarly to what was 
described previously for EEG findings in control dogs for disease with polygenic 
inheritance.  
5.5.2. Semi-quantitative analysis of FDG-PET 
The range of the asymmetry indexes was quite wide in the control dogs and the AIs on 
the visually identified hypo/hypermetabolic regions did not exceed the normal range. In 
epileptic human patients, asymmetry between 10-15% indicates possible areas of 
reduced glucose utilization and over 15% indicates clear regions of hypometabolism 
(Lamusuo et al. 2001). In study IV, AI of control and epileptic dogs had no significant 
variance in any regions and the highest value was 4.3. The highest AI was detected in 
the caudal colliculus, a minor structure where it also had a perfect match with 
asymmetry findings detected in the visual evaluation. The lack of asymmetry findings is 
suspected to be related to the VOI defining method. Partial hypometabolic findings can 
be masked with higher uptake of neighboring cortical areas when the VOI covers the 
wider cortical structures. Therefore to define the validity of asymmetry characteristics 
for cerebral glucose metabolism in epileptic dogs, new studies examining dogs with 
homologous clinical epilepsy manifestation with well defined ROIs guided by the 
results of visual analysis and drawn on the high resolution MR images would be 
optimal. 
Median SUV for whole brain for our control dogs was in compliance with results 
previously reported for dogs (Irimajiri et al. 2010, Lee et al. 2010, Hansen et al. 2011, 
Kang et al. 2012). In Study IV the highest regional uptake of FDG was found in the 
tectum (caudal colliculus). This has also been described in earlier reports and may be 
explained by the auditory reflex, which is also active in sedated dogs and is more 
prominent in some dog breeds (Irimajiri et al. 2010, Kang et al. 2012). The highest 
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cortical SUV was found in the temporal and parietal lobes, and the lowest in frontal and 
occipital lobes. This is in discrepancy with previous publications where the highest 
uptake in dogs was detected in nearly opposite order (Lee et al. 2010, Hansen et al. 
2011, Kang et al. 2012). A similar trend was also noticed in control FSDs, however 
there was no significant variability in FDG uptake of these cortical structures. 
Interestingly, dogs studied by SPECT have also shown a perfusion index that is highest 
in the occipital lobe, with a significant rostro-caudal perfusion gradient, and epileptic 
dogs were not significantly different from the healthy controls (Peremans et al. 2001, 
Martle et al. 2009). Therefore it is possible that such relative reduction of FDG uptake 
in the occipital lobe in the FSDs is a unique finding and may indirectly reflect the 
lowered seizure threshold in the occipital lobe, possibly characteristic of the breed or 
group of dog breeds. The lowest FDG uptake in dogs is reported to be in the brainstem, 
but this area was not measured in this study (Lee et al. 2010). In our study, FDG uptake 
in the cerebellar hemispheres was lower than in the vermis. Therefore the uptake 
variations within the substructures of larger anatomical structures should be cautiously 
considered when interpreting quantitative data (Kang et al. 2012).  
5.6. Comparisons between MRI, EEG, PET and phenotype (I-IV) 
5.6.1. Comparison of diagnostic modalities 
MRI results suggest that FSDs represent patients with non-lesional epilepsy and that 
MRI should be considered as a diagnostic modality for excluding other possible 
cerebral diseases causing seizures and not to confirm etiological background for 
seizures in our population. The conventional brain histopathology of 2 control and 3 
FSDs with epilepsy that were examined also failed to detect abnormalities (results not 
presented). Therefore no method to confirm validity of functional cerebral examinations 
in FSDs with epilepsy exists at the moment. We are the first to contrast EEG and FDG-
PET results in dogs (IV). EEG was less sensitive (36%) than FDG-PET (82%) and 
equally specific (both detected changes in 50% of control dogs) when all possible 
changes with epileptogenic nature were included. Both diagnostic modalities detected 
changes in the occipital region with highest specificity (100%) where EEG detected 
changes in 3 (27%) and FDG-PET in 7 (64%) out of 11 epileptic FSDs.  All occipital 
hypometabolic changes in FDG-PET were described as lateralized. In 2 epileptic dogs 
which had consensual occipital findings, EEG localized but didn’t lateralize the 
changes. In the third epileptic dog with lateralized occipital EEG findings, FDG-PET 
detected a hypermetabolic region that was suspected to be related to postictal changes. 
Therefore these results suggest that FDG-PET is a superior functional modality to detect 
changes in epileptic dogs originated from the occipital region. 
Complementary semi-quantitative analysis of FDG-PET determined the lowest SUV on 
the epileptic dogs in the occipital region. Moreover, control dogs also had the lowest 
SUV in the occipital lobe, contradictory with previous reports. Therefore we 
hypothesize that this finding may reflect the seizure susceptibility in this cortical region 
characteristic for the FSDs. Regional distribution of background activity bands was not 
investigated in the EEG study, therefore no supportive information was gathered from 
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other diagnostic modalities to validate this hypothesis arising from semi-quantitative 
results of FDG-PET. Despite the fact that FDG-PET demonstrated a higher diagnostic 
yield than EEG for detection of epilepsy related changes in FSDs, the use of PET for 
everyday clinical animal patients is impractical. EEG on the contrary is relatively easy 
to perform, and equipment is available at many veterinary institutions. Special training 
is also required, however, when performing the EEG and interpreting the results. 
The weakness of this study is that although EEG and FDG-PET results were largely in 
concordance, these findings were based on a small number of dogs. Therefore future 
studies will be needed to assert these findings. The association of changes in regional 
cerebral metabolism with the clinical signs of epilepsy and evolution of the cerebral 
metabolic pattern over time would be of great scientific interest.  
5.6.2. Comparison of epilepsy phenotype in FSDs and humans 
Characterizing epileptic seizures solely by seizure type lacks accuracy when type and 
time of ictal clinical signs is not specified. Special attention was paid to initial clinical 
signs of ictus when ictal phenomenology in FSDs was evaluated, to reveal the brain 
region generating these signs. Owners recognized initial signs preceding classical ictus 
in 68.5% of dogs. Behavioral signs like restlessness or anxiety were most consistently 
reported initial signs of the seizure. Named ictal signs are hard to link to some particular 
brain region in dogs as they might have multiple interpretations. However, other 
behavioral signs, like staring at one point with fixed eyes as described by some dog 
owners, might be more likely linked to visual signs, suspected with occipital-lobe 
epilepsy. Visual signs described in humans with occipital epilepsy include elementary 
visual hallucinations, visual illusions, blindness, or visual field defects (Lee et al. 2005). 
As there is no chance to obtain direct feedback from animal patients, the linkage of 
these behavioral signs commonly occurring in FSDs to the occipital region (suggested 
by functional examination), could not be confirmed nor excluded with confidence.  
Automatisms, motor or autonomic signs, or combination of these signs were also 
described as initial ictal signs in some FSDs. Autonomic signs like vomiting, observed 
in FSDs, have been reported to also occur in Border collies (Hülsmeyer et al. 2010). 
They have been recognized as a predominantly ictal phenomena in some human 
epilepsy syndromes (ie. Panayiotopoulos syndrome), that most typically arise from the 
occipital lobe. Ictal autonomic signs, however, seem to pertain to any epileptogenic 
cortical onset zone where ictal discharges activate the lower threshold autonomic 
network (insular cortex, medial prefrontal cortex, amygdale, hypothalamus, and 
ventrolateral medulla (Panayiotopoulos et al. 2008). Similar to FSDs, these autonomic 
seizures frequently have a long duration, but are still considered to present benign 
epilepsy. A different pathophysiological background for FSD epilepsy and 
Panayiotopoulos syndrome is likely, however as FSDs have an onset of epilepsy at an 
adult age, whereas maturation-related susceptibility of the central autonomic network 
specific for childhood epilepsy is the probable underlying mechanism of 
Panayiotopoulos syndrome (Panayiotopoulos et al. 2008). Autonomic signs, like 
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vomiting occur in adult humans rarely and usually when consciousness is impaired and 
following other focal mainly temporal symptoms (Koutroumandis 2003). Contrary 
autonomic signs following initial ictal signs were commonly observed in FSDs, 
salivation was the most frequent autonomic sign, but vomiting or regurgitation occurred 
in quarter of seizures. Motor signs which were also observed as initial ictal signs in 
some FSDs and were the most frequent symptom during further seizure progression 
usually indicate involvement of the frontal cortical structures (Foldvary-Schaefer & 
Unnwongse 2011).  
We conclude that although functional examinations most consistently indicate occipital 
lobe involvement, seizure phenotype of epilepsy in FSDs seems not to be exclusively 
uniform for that cortical region. Functional examinations in FSDs inconsistently showed 
involvement of other cortical regions. When combining these findings with the epilepsy 
phenotype, is likely that this breed experiences epilepsy with a genetic background 
which determines susceptibility to epileptogenesis in wider cortical regions, foremost 
posterior.  
Although many similarities between epilepsy in FSDs and humans can be shown, no 
human epilepsy syndrome was in line with FSDs epilepsy. This study indicates, 
however, that epilepsy in FSDs represents a fairly uniform phenotype and diagnostic 
characteristics to define it as a novel epilepsy syndrome in dogs, posterior focal IE. 
Further studies should assert whether posterior focal IE is typical for FSDs or if it might 
have a wider appearance in a variety of dog breeds.    
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6. CONCLUSIONS 
The major conclusions of the work presented in this thesis are: 
 Epilepsy in FSDs is characterized by focal seizures. Multiple criteria suggest a 
generally benign course of epilepsy, although the occurrence of a generalized 
seizure phase is a risk factor for the development of a progressive disease course 
in FSDs. Prevalence of epilepsy in the FSDs population in Finland is 5.3% and 
IE is inherited via polygenic traits. 
 Based on the current MRI study (1.5T), epilepsy in FSDs is non-lesional. Focal 
cerebral glucose hypometabolism in FDG-PET and paroxysmal epileptiform 
activity in EEG, both detected in the occipital region, were characteristic for 
epilepsy in FSDs. Although not reaching a significant level, EEG and FDG-PET 
findings in wider posterior cortical areas could be related to epilepsy in FSDs.  
 Visual evaluation of interictal FDG-PET is a sensitive method, but 
hypometabolic findings are highly specific for IE in FSDs only when detected in 
the occipital region. Diagnostic yield of interictal EEG for IE in FSDs remains 
lower. Results from two functional modalities (EEG and FDG-PET) used in 
control and epileptic FSDs were in concordance. Concomitant use of visual and 
quantitative analysis of EEG and FDG-PET in epileptic dogs is advised as 
complementary information can be achieved. Further research on the larger 
cohort of epileptic dogs will be needed to evaluate concordance of the EEG and 
FDG-PET findings, and results interpreted in light of the clinical signs.  
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